| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.592 | 0.037 | 0.678 | Caspase 9 stimulant | 0.678 0.026 DB00316 0.593 0.037 DBMET01974 | DB00316 | |
| 0.552 | 0.003 | 0.552 | Cyclooxygenase 3 inhibitor | 0.314 0.005 DB00316 0.263 0.008 DBMET01974 | ||
| 0.563 | 0.017 | 0.61 | 5 Hydroxytryptamine release inhibitor | 0.61 0.01 DB00316 0.577 0.014 DBMET01974 | DB00316 | |
| 0.428 | 0.005 | 0.741 | Chelator | 0.139 0.04 DB00316 0.741 0.002 DBMET01974 | DBMET01974 | |
| 0.462 | 0.044 | 0.575 | Histamine release inhibitor | 0.575 0.013 DB00316 0.523 0.022 DBMET01974 | DB00316 | |
| 0.413 | 0.017 | 0.462 | Interleukin agonist | 0.462 0.012 DB00316 0.366 0.025 DBMET01974 | DB00316 | |
| 0.416 | 0.024 | 0.796 | Superoxide dismutase inhibitor | 0.405 0.026 DB00316 0.796 0.003 DBMET01974 | DBMET01974 | |
| 0.432 | 0.048 | 0.569 | GABA C receptor rho-3 antagonist | 0.569 0.011 DB00316 0.517 0.021 DBMET01974 | DB00316 | |
| 0.415 | 0.051 | 0.498 | Vasodilator, peripheral | 0.392 0.058 DB00316 0.498 0.028 DBMET01974 | DBMET01974 | |
| 0.364 | 0.01 | 0.551 | Peptidyltransferase inhibitor | 0.316 0.019 DB00316 0.551 0.003 DBMET01974 | DBMET01974 | |
| 0.369 | 0.027 | 0.513 | Sigma receptor agonist | 0.513 0.009 DBMET01974 | DBMET01974 | |
| 0.357 | 0.027 | 0.659 | Peroxidase inhibitor | 0.646 0.004 DB00316 0.659 0.004 DBMET01974 | DBMET01974 | |
| 0.343 | 0.025 | 0.463 | Anesthetic general | 0.381 0.019 DB00316 0.463 0.01 DBMET01974 | DBMET01974 | |
| 0.329 | 0.013 | 0.725 | Alpha-N-acetylglucosaminidase inhibitor | 0.677 0.003 DB00316 0.725 0.003 DBMET01974 | DBMET01974 | |
| 0.329 | 0.022 | 0.671 | Tyrosine 3 hydroxylase inhibitor | 0.41 0.007 DB00316 0.671 0.003 DBMET01974 | DBMET01974 | |
| 0.346 | 0.042 | 0.346 | DNA damaging | 0.223 0.098 DB00316 0.306 0.055 DBMET01974 | ||
| 0.347 | 0.047 | 0.469 | Interleukin 2 agonist | 0.469 0.012 DB00316 0.33 0.055 DBMET01974 | DB00316 | |
| 0.314 | 0.02 | 0.361 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.361 0.011 DB00316 0.323 0.018 DBMET01974 | DB00316 | |
| 0.291 | 0.029 | 0.298 | DNA methyltransferase I inhibitor | 0.271 0.038 DB00316 0.298 0.027 DBMET01974 | DBMET01974 | |
| 0.313 | 0.051 | 0.574 | Cardiotonic | 0.574 0.009 DBMET01974 | DBMET01974 | |
| 0.31 | 0.053 | 0.4 | Insulysin inhibitor | 0.355 0.032 DB00316 0.4 0.022 DBMET01974 | DBMET01974 | |
| 0.269 | 0.016 | 0.269 | Anesthetic local | 0.155 0.046 DB00316 0.239 0.022 DBMET01974 | ||
| 0.287 | 0.042 | 0.358 | Gastrin inhibitor | 0.282 0.047 DB00316 0.358 0.009 DBMET01974 | DBMET01974 | |
| 0.276 | 0.033 | 0.297 | Neuropeptide Y2 antagonist | 0.297 0.02 DB00316 0.256 0.051 DBMET01974 | DB00316 | |
| 0.284 | 0.042 | 0.317 | 5 Hydroxytryptamine 1E antagonist | 0.317 0.02 DB00316 0.215 0.114 DBMET01974 | DB00316 | |
| 0.311 | 0.075 | 0.385 | Immunostimulant | 0.337 0.068 DB00316 0.385 0.054 DBMET01974 | DBMET01974 | |
| 0.272 | 0.038 | 0.288 | DNA methylase inhibitor | 0.242 0.053 DB00316 0.288 0.032 DBMET01974 | DBMET01974 | |
| 0.234 | 0.009 | 0.866 | Porphobilinogen synthase inhibitor | 0.254 0.007 DB00316 0.866 0.001 DBMET01974 | DBMET01974 | |
| 0.285 | 0.07 | 0.845 | Aldehyde oxidase inhibitor | 0.559 0.025 DB00316 0.845 0.004 DBMET01974 | DBMET01974 | |
| 0.236 | 0.023 | 0.241 | 5 Hydroxytryptamine 3E antagonist | 0.241 0.02 DB00316 0.207 0.052 DBMET01974 | DB00316 | |
| 0.29 | 0.095 | 0.426 | Vasodilator, coronary | 0.247 0.138 DB00316 0.426 0.028 DBMET01974 | DBMET01974 | |
| 0.347 | 0.154 | 0.476 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.476 0.045 DB00316 0.413 0.09 DBMET01974 | DB00316 | |
| 0.303 | 0.113 | 0.401 | Calpain 2 inhibitor | 0.401 0.061 DB00316 0.217 0.174 DBMET01974 | DB00316 | |
| 0.213 | 0.023 | 0.245 | Alkylator | 0.155 0.044 DB00316 0.245 0.017 DBMET01974 | DBMET01974 | |
| 0.214 | 0.026 | 0.294 | Death-associated protein kinase 2 inhibitor | 0.294 0.007 DB00316 | DB00316 | |
| 0.203 | 0.014 | 0.203 | Topoisomerase II alpha inhibitor | 0.136 0.026 DB00316 | ||
| 0.228 | 0.041 | 0.405 | Lipocortins synthesis antagonist | 0.405 0.008 DBMET01974 | DBMET01974 | |
| 0.271 | 0.096 | 0.271 | Caspase 3 stimulant | 0.257 0.106 DB00316 | ||
| 0.186 | 0.017 | 0.227 | Mucolytic | 0.21 0.011 DB00316 0.227 0.009 DBMET01974 | DBMET01974 | |
| 0.172 | 0.005 | 0.232 | Neuraminidase (influenza) inhibitor | 0.232 0.004 DB00316 0.071 0.034 DBMET01974 | DB00316 | |
| 0.274 | 0.11 | 0.352 | Transcription factor NF kappa B inhibitor | 0.352 0.076 DB00316 0.285 0.103 DBMET01974 | DB00316 | |
| 0.197 | 0.034 | 0.197 | Topoisomerase II inhibitor | 0.131 0.059 DB00316 0.145 0.052 DBMET01974 | ||
| 0.199 | 0.038 | 0.234 | ATPase inhibitor | 0.234 0.018 DB00316 0.211 0.029 DBMET01974 | DB00316 | |
| 0.236 | 0.078 | 0.236 | Antiamyloidogenic | 0.208 0.094 DB00316 0.217 0.088 DBMET01974 | ||
| 0.196 | 0.049 | 0.258 | Cytidine deaminase inhibitor | 0.204 0.046 DB00316 0.258 0.027 DBMET01974 | DBMET01974 | |
| 0.159 | 0.015 | 0.576 | NADH dehydrogenase inhibitor | 0.152 0.017 DB00316 0.576 0.002 DBMET01974 | DBMET01974 | |
| 0.149 | 0.006 | 0.224 | Neuraminidase inhibitor | 0.224 0.004 DB00316 0.061 0.042 DBMET01974 | DB00316 | |
| 0.212 | 0.07 | 0.3 | Nitric-oxide synthase stimulant | 0.3 0.011 DB00316 0.242 0.038 DBMET01974 | DB00316 | |
| 0.235 | 0.096 | 0.372 | Transcription factor STAT3 inhibitor | 0.372 0.026 DB00316 0.182 0.16 DBMET01974 | DB00316 | |
| 0.169 | 0.031 | 0.439 | Ferrochelatase inhibitor | 0.341 0.005 DB00316 0.439 0.003 DBMET01974 | DBMET01974 | |
| 0.205 | 0.067 | 0.261 | Non-steroidal antiinflammatory agent | 0.184 0.084 DB00316 0.261 0.039 DBMET01974 | DBMET01974 | |
| 0.21 | 0.073 | 0.252 | Amyloid beta aggregation inhibitor | 0.252 0.057 DB00316 0.203 0.076 DBMET01974 | DB00316 | |
| 0.155 | 0.019 | 0.401 | Alcohol dehydrogenase inhibitor | 0.145 0.022 DB00316 0.401 0.004 DBMET01974 | DBMET01974 | |
| 0.264 | 0.131 | 0.415 | Calcium channel activator | 0.307 0.085 DB00316 0.415 0.019 DBMET01974 | DBMET01974 | |
| 0.169 | 0.04 | 0.236 | Toll-Like receptor 2 antagonist | 0.236 0.012 DB00316 0.196 0.025 DBMET01974 | DB00316 | |
| 0.152 | 0.025 | 0.322 | Catalase inhibitor | 0.226 0.011 DB00316 0.322 0.005 DBMET01974 | DBMET01974 | |
| 0.173 | 0.047 | 0.177 | Hemostatic | 0.173 0.047 DB00316 0.177 0.044 DBMET01974 | DBMET01974 | |
| 0.154 | 0.034 | 0.211 | Expectorant | 0.197 0.021 DB00316 0.211 0.018 DBMET01974 | DBMET01974 | |
| 0.295 | 0.175 | 0.295 | Apoptosis agonist | 0.292 0.178 DB00316 | ||
| 0.161 | 0.045 | 0.208 | Sphingosine 1-phosphate receptor 5 antagonist | 0.208 0.009 DB00316 0.167 0.037 DBMET01974 | DB00316 | |
| 0.148 | 0.033 | 0.154 | TRPA1 agonist | 0.154 0.028 DB00316 0.143 0.036 DBMET01974 | DB00316 | |
| 0.204 | 0.09 | 0.314 | Cyclic AMP phosphodiesterase inhibitor | 0.243 0.067 DB00316 0.314 0.036 DBMET01974 | DBMET01974 | |
| 0.128 | 0.014 | 0.128 | Potassium channel large-conductance Ca-activated activator | 0.066 0.049 DBMET01974 | ||
| 0.14 | 0.027 | 0.254 | Prolactin inhibitor | 0.152 0.021 DB00316 0.254 0.004 DBMET01974 | DBMET01974 | |
| 0.133 | 0.019 | 0.133 | Carbonic anhydrase inhibitor | 0.097 0.028 DB00316 0.1 0.027 DBMET01974 | ||
| 0.166 | 0.055 | 0.24 | GABA C receptor rho-2 antagonist | 0.218 0.02 DB00316 0.24 0.014 DBMET01974 | DBMET01974 | |
| 0.123 | 0.017 | 0.622 | Phenylalanine 4-hydroxylase inhibitor | 0.187 0.008 DB00316 0.622 0.002 DBMET01974 | DBMET01974 | |
| 0.109 | 0.006 | 0.109 | Carbonic anhydrase IV inhibitor | 0.071 0.014 DB00316 0.099 0.007 DBMET01974 | ||
| 0.22 | 0.117 | 0.44 | 5 Hydroxytryptamine uptake stimulant | 0.325 0.034 DB00316 0.44 0.008 DBMET01974 | DBMET01974 | |
| 0.117 | 0.014 | 0.192 | NMDA receptor agonist | 0.172 0.006 DB00316 0.192 0.005 DBMET01974 | DBMET01974 | |
| 0.143 | 0.041 | 0.248 | Papain-like protease (SARS coronavirus) inhibitor | 0.248 0.005 DB00316 | DB00316 | |
| 0.113 | 0.011 | 0.154 | NMDA receptor glycine site agonist | 0.154 0.004 DB00316 0.126 0.007 DBMET01974 | DB00316 | |
| 0.133 | 0.033 | 0.194 | Sphingomyelinase inhibitor | 0.101 0.059 DB00316 0.194 0.011 DBMET01974 | DBMET01974 | |
| 0.171 | 0.073 | 0.269 | 3C-like protease (Human coronavirus) inhibitor | 0.269 0.02 DB00316 | DB00316 | |
| 0.209 | 0.112 | 0.427 | Spasmolytic | 0.169 0.146 DB00316 0.427 0.035 DBMET01974 | DBMET01974 | |
| 0.143 | 0.046 | 0.17 | Vanilloid 1 agonist | 0.155 0.033 DB00316 0.17 0.023 DBMET01974 | DBMET01974 | |
| 0.128 | 0.031 | 0.306 | Electrolyte absorption antagonist | 0.14 0.024 DB00316 0.306 0.004 DBMET01974 | DBMET01974 | |
| 0.235 | 0.139 | 0.434 | Antithrombotic | 0.27 0.111 DB00316 0.434 0.041 DBMET01974 | DBMET01974 | |
| 0.098 | 0.004 | 0.103 | Neuraminidase (Influenza A) inhibitor | 0.103 0.004 DB00316 0.056 0.016 DBMET01974 | DB00316 | |
| 0.192 | 0.099 | 0.236 | ErbB-1 antagonist | 0.236 0.059 DB00316 | DB00316 | |
| 0.114 | 0.021 | 0.194 | Glycine receptor antagonist | 0.128 0.014 DB00316 0.194 0.004 DBMET01974 | DBMET01974 | |
| 0.143 | 0.051 | 0.189 | Sphingosine 1-phosphate receptor 2 antagonist | 0.189 0.011 DB00316 0.157 0.033 DBMET01974 | DB00316 | |
| 0.139 | 0.048 | 0.139 | DNA intercalator | 0.093 0.081 DBMET01974 | ||
| 0.106 | 0.017 | 0.106 | Carbonic anhydrase II inhibitor | 0.082 0.024 DB00316 0.078 0.026 DBMET01974 | ||
| 0.166 | 0.079 | 0.429 | Phospholipase C inhibitor | 0.257 0.024 DB00316 0.429 0.009 DBMET01974 | DBMET01974 | |
| 0.135 | 0.048 | 0.135 | Topoisomerase I inhibitor | 0.099 0.071 DBMET01974 | ||
| 0.125 | 0.038 | 0.141 | Potassium channel (Ca-activated) activator | 0.127 0.037 DB00316 0.141 0.031 DBMET01974 | DBMET01974 | |
| 0.113 | 0.027 | 0.159 | Glutathione S-transferase inhibitor | 0.126 0.019 DB00316 0.159 0.01 DBMET01974 | DBMET01974 | |
| 0.124 | 0.037 | 0.264 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.264 0.009 DB00316 0.257 0.009 DBMET01974 | DB00316 | |
| 0.103 | 0.017 | 0.103 | Carbonic anhydrase I inhibitor | 0.081 0.025 DB00316 0.082 0.024 DBMET01974 | ||
| 0.245 | 0.159 | 0.245 | Beta lactamase inhibitor | 0.206 0.181 DB00316 | ||
| 0.191 | 0.106 | 0.427 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.427 0.032 DB00316 | DB00316 | |
| 0.104 | 0.02 | 0.132 | Estrogen-related receptor beta agonist | 0.128 0.007 DB00316 0.132 0.006 DBMET01974 | DBMET01974 | |
| 0.124 | 0.04 | 0.427 | Adenylate kinase inhibitor | 0.146 0.028 DB00316 0.427 0.003 DBMET01974 | DBMET01974 | |
| 0.167 | 0.084 | 0.352 | Succinate dehydrogenase inhibitor | 0.29 0.012 DB00316 0.352 0.005 DBMET01974 | DBMET01974 | |
| 0.226 | 0.143 | 0.536 | Cholesterol antagonist | 0.344 0.067 DB00316 0.536 0.027 DBMET01974 | DBMET01974 | |
| 0.143 | 0.06 | 0.253 | NADPH oxidase inhibitor | 0.253 0.02 DB00316 0.171 0.044 DBMET01974 | DB00316 | |
| 0.122 | 0.042 | 0.126 | Gastric antisecretory | 0.126 0.039 DBMET01974 | DBMET01974 | |
| 0.103 | 0.023 | 0.103 | Amidase inhibitor | 0.09 0.03 DB00316 | ||
| 0.207 | 0.128 | 0.387 | Transcription factor STAT inhibitor | 0.387 0.022 DB00316 | DB00316 | |
| 0.114 | 0.037 | 0.128 | Glutamate (mGluR7) agonist | 0.128 0.023 DB00316 0.113 0.038 DBMET01974 | DB00316 | |
| 0.15 | 0.074 | 0.278 | Phospholipase A2 inhibitor | 0.148 0.076 DB00316 0.278 0.017 DBMET01974 | DBMET01974 | |
| 0.135 | 0.058 | 0.62 | Aldehyde dehydrogenase inhibitor | 0.149 0.048 DB00316 0.62 0.004 DBMET01974 | DBMET01974 | |
| 0.194 | 0.118 | 0.304 | Antioxidant | 0.273 0.073 DB00316 0.304 0.06 DBMET01974 | DBMET01974 | |
| 0.127 | 0.051 | 0.162 | Caspase 3 inhibitor | 0.156 0.024 DB00316 0.162 0.02 DBMET01974 | DBMET01974 | |
| 0.104 | 0.031 | 0.104 | Telomerase inhibitor | 0.099 0.034 DB00316 | ||
| 0.22 | 0.148 | 0.256 | Angiogenesis inhibitor | 0.256 0.119 DB00316 | DB00316 | |
| 0.102 | 0.031 | 0.102 | Vanilloid agonist | 0.078 0.075 DBMET01974 | ||
| 0.162 | 0.094 | 0.205 | Platelet adhesion inhibitor | 0.205 0.069 DBMET01974 | DBMET01974 | |
| 0.135 | 0.067 | 0.146 | MAO inhibitor | 0.146 0.062 DB00316 0.097 0.094 DBMET01974 | DB00316 | |
| 0.081 | 0.013 | 0.132 | Topoisomerase II beta inhibitor | 0.132 0.006 DB00316 0.09 0.011 DBMET01974 | DB00316 | |
| 0.172 | 0.105 | 0.256 | Insulin sensitizer | 0.215 0.059 DB00316 0.256 0.031 DBMET01974 | DBMET01974 | |
| 0.224 | 0.157 | 0.458 | Sodium/bile acid cotransporter inhibitor | 0.329 0.055 DB00316 0.458 0.006 DBMET01974 | DBMET01974 | |
| 0.101 | 0.04 | 0.101 | Platelet growth factor antagonist | |||
| 0.069 | 0.008 | 0.069 | Benzodiazepine antagonist | 0.044 0.042 DB00316 0.049 0.029 DBMET01974 | ||
| 0.08 | 0.02 | 0.097 | Heat shock protein 90 beta antagonist | 0.097 0.012 DB00316 0.078 0.022 DBMET01974 | DB00316 | |
| 0.073 | 0.014 | 0.096 | Ryanodine receptor antagonist | 0.065 0.025 DB00316 0.096 0.005 DBMET01974 | DBMET01974 | |
| 0.123 | 0.065 | 0.254 | Adenylate cyclase inhibitor | 0.15 0.045 DB00316 0.254 0.019 DBMET01974 | DBMET01974 | |
| 0.109 | 0.052 | 0.34 | UDP-glucose 4-epimerase inhibitor | 0.34 0.008 DB00316 0.226 0.015 DBMET01974 | DB00316 | |
| 0.113 | 0.056 | 0.299 | Aminopeptidase B inhibitor | 0.157 0.035 DB00316 0.299 0.008 DBMET01974 | DBMET01974 | |
| 0.102 | 0.046 | 0.102 | Thioredoxin inhibitor | 0.099 0.049 DB00316 | ||
| 0.098 | 0.042 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.087 0.063 DB00316 | ||
| 0.209 | 0.154 | 0.306 | Thyroid hormone antagonist | 0.306 0.09 DB00316 | DB00316 | |
| 0.089 | 0.037 | 0.505 | Glutamate dehydrogenase inhibitor | 0.125 0.021 DB00316 0.505 0.003 DBMET01974 | DBMET01974 | |
| 0.114 | 0.063 | 0.173 | CDK3/cyclin E inhibitor | 0.173 0.014 DB00316 | DB00316 | |
| 0.076 | 0.026 | 0.076 | Nitric oxide donor | 0.069 0.034 DBMET01974 | ||
| 0.122 | 0.072 | 0.125 | Nav1.3 sodium channel blocker | 0.11 0.086 DB00316 0.125 0.069 DBMET01974 | DBMET01974 | |
| 0.107 | 0.058 | 0.317 | Carbonic anhydrase XV inhibitor | 0.317 0.007 DB00316 0.108 0.057 DBMET01974 | DB00316 | |
| 0.103 | 0.058 | 0.341 | Carbonic anhydrase III inhibitor | 0.341 0.005 DB00316 0.142 0.032 DBMET01974 | DB00316 | |
| 0.157 | 0.113 | 0.401 | Interleukin antagonist | 0.401 0.031 DB00316 | DB00316 | |
| 0.101 | 0.057 | 0.16 | Interleukin 1 beta converting enzyme inhibitor | 0.129 0.028 DB00316 0.16 0.014 DBMET01974 | DBMET01974 | |
| 0.199 | 0.155 | 0.29 | Thyroid hormone beta antagonist | 0.29 0.093 DB00316 | DB00316 | |
| 0.167 | 0.126 | 0.286 | Free radical scavenger | 0.286 0.055 DB00316 0.23 0.078 DBMET01974 | DB00316 | |
| 0.146 | 0.105 | 0.206 | Cyclin-dependent kinase 3 inhibitor | 0.206 0.03 DB00316 | DB00316 | |
| 0.178 | 0.137 | 0.252 | Calpain inhibitor | 0.252 0.063 DB00316 0.185 0.129 DBMET01974 | DB00316 | |
| 0.048 | 0.008 | 0.048 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.031 DBMET01974 | ||
| 0.195 | 0.157 | 0.322 | Hypoxia-inducible factor 1 alpha inhibitor | 0.218 0.131 DB00316 0.322 0.056 DBMET01974 | DBMET01974 | |
| 0.08 | 0.042 | 0.284 | Aminopeptidase I inhibitor | 0.101 0.027 DB00316 0.284 0.003 DBMET01974 | DBMET01974 | |
| 0.1 | 0.063 | 0.16 | Anabolic | 0.15 0.018 DB00316 0.16 0.013 DBMET01974 | DBMET01974 | |
| 0.052 | 0.016 | 0.125 | Dihydropteroate synthase inhibitor | 0.125 0.004 DB00316 0.052 0.015 DBMET01974 | DB00316 | |
| 0.076 | 0.04 | 0.164 | Carbonic anhydrase VA inhibitor | 0.164 0.008 DB00316 0.073 0.043 DBMET01974 | DB00316 | |
| 0.147 | 0.112 | 0.203 | Catenin beta inhibitor | 0.203 0.03 DB00316 0.181 0.051 DBMET01974 | DB00316 | |
| 0.099 | 0.064 | 0.226 | GABA C receptor rho-1 antagonist | 0.153 0.02 DB00316 0.226 0.005 DBMET01974 | DBMET01974 | |
| 0.101 | 0.066 | 0.575 | GABA C receptor agonist | 0.229 0.016 DB00316 0.575 0.003 DBMET01974 | DBMET01974 | |
| 0.069 | 0.036 | 0.133 | Beta 3 adrenoreceptor antagonist | 0.133 0.008 DB00316 0.07 0.034 DBMET01974 | DB00316 | |
| 0.13 | 0.097 | 0.202 | Heat shock protein 90 antagonist | 0.202 0.037 DB00316 | DB00316 | |
| 0.066 | 0.035 | 0.124 | Carbonic anhydrase stimulant | 0.061 0.04 DB00316 0.124 0.014 DBMET01974 | DBMET01974 | |
| 0.1 | 0.07 | 0.21 | Falcipain 3 inhibitor | 0.21 0.015 DB00316 | DB00316 | |
| 0.064 | 0.034 | 0.08 | Beta 2 adrenoreceptor agonist | 0.08 0.009 DB00316 0.066 0.028 DBMET01974 | DB00316 | |
| 0.114 | 0.085 | 0.396 | Amylase inhibitor | 0.224 0.036 DB00316 0.396 0.009 DBMET01974 | DBMET01974 | |
| 0.038 | 0.01 | 0.038 | Elastase 2B inhibitor | |||
| 0.038 | 0.01 | 0.038 | Elastase 3A inhibitor | |||
| 0.038 | 0.01 | 0.038 | Elastase 3B inhibitor | |||
| 0.104 | 0.078 | 0.127 | Acetylcholine release stimulant | 0.106 0.075 DB00316 0.127 0.037 DBMET01974 | DBMET01974 | |
| 0.041 | 0.016 | 0.082 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.037 0.019 DB00316 0.082 0.005 DBMET01974 | DBMET01974 | |
| 0.04 | 0.015 | 0.04 | Melatonin 2 agonist | 0.035 0.02 DB00316 | ||
| 0.067 | 0.043 | 0.102 | Beta adrenoreceptor antagonist | 0.102 0.015 DB00316 0.081 0.026 DBMET01974 | DB00316 | |
| 0.084 | 0.06 | 0.084 | Antineoplastic alkaloid | 0.076 0.07 DBMET01974 | ||
| 0.088 | 0.064 | 0.141 | Potassium channel activator | 0.141 0.023 DB00316 | DB00316 | |
| 0.028 | 0.005 | 0.041 | Neuraminidase (Influenza B) inhibitor | 0.041 0.003 DB00316 0.032 0.004 DBMET01974 | DB00316 | |
| 0.028 | 0.004 | 0.036 | Estrogen-related receptor gamma agonist | 0.036 0.003 DB00316 0.027 0.005 DBMET01974 | DB00316 | |
| 0.033 | 0.01 | 0.043 | Estrogen-related receptor gamma antagonist | 0.043 0.004 DB00316 0.043 0.004 DBMET01974 | DBMET01974 | |
| 0.082 | 0.059 | 0.127 | CC chemokine 5 receptor agonist | 0.127 0.006 DB00316 0.092 0.033 DBMET01974 | DB00316 | |
| 0.114 | 0.091 | 0.143 | Antibacterial (Helicobacter pylori) | 0.143 0.053 DB00316 0.114 0.091 DBMET01974 | DB00316 | |
| 0.067 | 0.046 | 0.181 | Carbonic anhydrase V inhibitor | 0.181 0.009 DB00316 0.066 0.046 DBMET01974 | DB00316 | |
| 0.058 | 0.037 | 0.678 | Alcohol oxidase inhibitor | 0.678 0.003 DB00316 0.576 0.003 DBMET01974 | DB00316 | |
| 0.037 | 0.018 | 0.037 | Melatonin 1 agonist | 0.031 0.027 DB00316 | ||
| 0.054 | 0.036 | 0.224 | Alpha-mannosidase inhibitor | 0.065 0.021 DB00316 0.224 0.003 DBMET01974 | DBMET01974 | |
| 0.103 | 0.085 | 0.152 | Microtubule formation inhibitor | 0.118 0.063 DB00316 0.152 0.036 DBMET01974 | DBMET01974 | |
| 0.059 | 0.041 | 0.06 | Gonadotropin-releasing hormone receptor agonist | 0.059 0.041 DB00316 0.06 0.039 DBMET01974 | DBMET01974 | |
| 0.053 | 0.036 | 0.076 | Heparanase inhibitor | 0.076 0.008 DB00316 0.058 0.026 DBMET01974 | DB00316 | |
| 0.05 | 0.035 | 0.05 | Sodium/calcium exchanger inhibitor | |||
| 0.08 | 0.067 | 0.14 | Histamine N-methyltransferase inhibitor | 0.092 0.053 DB00316 0.14 0.018 DBMET01974 | DBMET01974 | |
| 0.053 | 0.04 | 0.234 | Acyl-CoA dehydrogenase inhibitor | 0.087 0.02 DB00316 0.234 0.004 DBMET01974 | DBMET01974 | |
| 0.094 | 0.081 | 0.229 | Monophenol monooxygenase inhibitor | 0.229 0.027 DB00316 0.146 0.048 DBMET01974 | DB00316 | |
| 0.034 | 0.021 | 0.034 | Melatonin agonist | 0.03 0.028 DB00316 | ||
| 0.038 | 0.025 | 0.051 | Diamine oxidase inhibitor | 0.051 0.014 DB00316 | DB00316 | |
| 0.111 | 0.099 | 0.287 | Interleukin 4 antagonist | 0.287 0.009 DB00316 | DB00316 | |
| 0.107 | 0.095 | 0.159 | Cathepsin H inhibitor | 0.152 0.045 DB00316 0.159 0.04 DBMET01974 | DBMET01974 | |
| 0.057 | 0.045 | 0.097 | Androgen agonist | 0.097 0.016 DB00316 0.082 0.023 DBMET01974 | DB00316 | |
| 0.08 | 0.069 | 0.169 | D-Ala-D-Ala ligase inhibitor | 0.169 0.004 DB00316 0.095 0.035 DBMET01974 | DB00316 | |
| 0.099 | 0.088 | 0.132 | Proteasome inhibitor | 0.132 0.057 DB00316 0.106 0.079 DBMET01974 | DB00316 | |
| 0.045 | 0.034 | 0.056 | Beta adrenoreceptor agonist | 0.056 0.01 DB00316 0.046 0.029 DBMET01974 | DB00316 | |
| 0.14 | 0.129 | 0.223 | Neurotensin receptor agonist | 0.223 0.026 DB00316 0.198 0.036 DBMET01974 | DB00316 | |
| 0.112 | 0.102 | 0.207 | Lipid peroxidase inhibitor | 0.207 0.039 DB00316 0.162 0.06 DBMET01974 | DB00316 | |
| 0.064 | 0.055 | 0.064 | Elastase 1 inhibitor | |||
| 0.06 | 0.05 | 0.091 | Histone deacetylase SIRT3 inhibitor | 0.091 0.013 DB00316 | DB00316 | |
| 0.073 | 0.065 | 0.161 | Interferon agonist | 0.072 0.066 DB00316 0.161 0.009 DBMET01974 | DBMET01974 | |
| 0.063 | 0.055 | 0.093 | Potassium channel (ATP-sensitive) blocker | 0.093 0.019 DB00316 | DB00316 | |
| 0.026 | 0.019 | 0.057 | Thyroid hormone agonist | 0.057 0.004 DB00316 0.045 0.005 DBMET01974 | DB00316 | |
| 0.081 | 0.075 | 0.313 | Triose-phosphate isomerase inhibitor | 0.172 0.015 DB00316 0.313 0.005 DBMET01974 | DBMET01974 | |
| 0.066 | 0.06 | 0.074 | Epoxide hydrolase inhibitor | 0.074 0.048 DB00316 | DB00316 | |
| 0.135 | 0.13 | 0.332 | Psychostimulant | 0.159 0.108 DB00316 0.332 0.035 DBMET01974 | DBMET01974 | |
| 0.155 | 0.15 | 0.353 | Vasodilator | 0.353 0.032 DBMET01974 | DBMET01974 | |
| 0.042 | 0.037 | 0.192 | Mannosidase inhibitor | 0.054 0.021 DB00316 0.192 0.003 DBMET01974 | DBMET01974 | |
| 0.073 | 0.068 | 0.135 | Adrenaline agonist | 0.135 0.019 DB00316 0.084 0.053 DBMET01974 | DB00316 | |
| 0.082 | 0.078 | 0.082 | Platelet activating factor alpha antagonist | |||
| 0.046 | 0.042 | 0.088 | Squalene epoxidase inhibitor | 0.088 0.007 DBMET01974 | DBMET01974 | |
| 0.144 | 0.14 | 0.445 | Aryl hydrocarbon receptor agonist | 0.445 0.03 DB00316 | DB00316 | |
| 0.075 | 0.071 | 0.164 | Androgen antagonist | 0.164 0.019 DB00316 | DB00316 | |
| 0.109 | 0.106 | 0.219 | Protein kinase stimulant | 0.219 0.035 DB00316 0.165 0.058 DBMET01974 | DB00316 | |
| 0.231 | 0.228 | 0.498 | Calcium channel L-type activator | 0.498 0.029 DB00316 0.253 0.202 DBMET01974 | DB00316 | |
| 0.086 | 0.083 | 0.159 | Urease inhibitor | 0.159 0.019 DB00316 0.12 0.045 DBMET01974 | DB00316 | |
| 0.032 | 0.03 | 0.122 | Arginase inhibitor | 0.034 0.028 DB00316 0.122 0.003 DBMET01974 | DBMET01974 | |
| 0.033 | 0.032 | 0.033 | Adenosine uptake inhibitor | |||
| 0.126 | 0.127 | 0.231 | CF transmembrane conductance regulator agonist | 0.231 0.01 DB00316 | DB00316 | |
| 0.014 | 0.015 | 0.052 | Ileal bile acid transport inhibitor | 0.024 0.007 DB00316 0.052 0.003 DBMET01974 | DBMET01974 | |
| 0.05 | 0.051 | 0.141 | Dihydroorotate oxidase inhibitor | 0.141 0.003 DB00316 | DB00316 | |
| 0.031 | 0.032 | 0.045 | Leukotriene A4 hydrolase inhibitor | 0.045 0.022 DBMET01974 | DBMET01974 | |
| 0.105 | 0.107 | 0.179 | Alkaline phosphatase inhibitor | 0.179 0.043 DB00316 0.157 0.055 DBMET01974 | DB00316 | |
| 0.011 | 0.014 | 0.024 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.006 DB00316 0.024 0.003 DBMET01974 | DBMET01974 | |
| 0.029 | 0.032 | 0.036 | GHS receptor antagonist | 0.036 0.016 DBMET01974 | DBMET01974 | |
| 0.05 | 0.053 | 0.157 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.157 0.006 DB00316 0.056 0.044 DBMET01974 | DB00316 | |
| 0.018 | 0.022 | 0.021 | Factor XIII inhibitor | 0.021 0.014 DB00316 | DB00316 | |
| 0.013 | 0.017 | 0.029 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 DB00316 0.029 0.004 DBMET01974 | DBMET01974 | |
| 0.013 | 0.017 | 0.029 | Carbonic anhydrase X inhibitor | 0.024 0.006 DB00316 0.029 0.004 DBMET01974 | DBMET01974 | |
| 0.047 | 0.051 | 0.085 | Beta 1 adrenoreceptor antagonist | 0.085 0.015 DB00316 0.055 0.041 DBMET01974 | DB00316 | |
| 0.09 | 0.095 | 0.263 | GABA C receptor antagonist | 0.168 0.022 DB00316 0.263 0.005 DBMET01974 | DBMET01974 | |
| 0.082 | 0.087 | 0.122 | Lanosterol 14 alpha demethylase inhibitor | 0.119 0.032 DB00316 0.122 0.028 DBMET01974 | DBMET01974 | |
| 0.043 | 0.048 | 0.082 | Beta 2 adrenoreceptor antagonist | 0.082 0.011 DB00316 0.058 0.026 DBMET01974 | DB00316 | |
| 0.027 | 0.033 | 0.044 | Growth hormone secretagogue receptor antagonist | 0.044 0.02 DBMET01974 | DBMET01974 | |
| 0.01 | 0.015 | 0.018 | Carbonic anhydrase XI inhibitor | 0.018 0.005 DB00316 | DB00316 | |
| 0.026 | 0.032 | 0.037 | Epoxide hydrolase 1 inhibitor | 0.037 0.014 DB00316 | DB00316 | |
| 0.138 | 0.144 | 0.254 | Anticonvulsant | 0.254 0.056 DBMET01974 | DBMET01974 | |
| 0.12 | 0.127 | 0.241 | Heat shock protein 90 alpha antagonist | 0.241 0.03 DB00316 | DB00316 | |
| 0.033 | 0.04 | 0.116 | Membrane dipeptidase inhibitor | 0.037 0.031 DB00316 0.116 0.003 DBMET01974 | DBMET01974 | |
| 0.083 | 0.09 | 0.151 | Mediator release inhibitor | 0.151 0.028 DB00316 0.114 0.054 DBMET01974 | DB00316 | |
| 0.035 | 0.042 | 0.047 | Leukocyte elastase inhibitor | 0.047 0.026 DBMET01974 | DBMET01974 | |
| 0.074 | 0.081 | 0.079 | MAO B inhibitor | 0.079 0.076 DB00316 | DB00316 | |
| 0.026 | 0.035 | 0.04 | Methionyl aminopeptidase 1 inhibitor | 0.04 0.012 DB00316 | DB00316 | |
| 0.188 | 0.197 | 0.335 | Apoptosis antagonist | 0.283 0.098 DB00316 0.335 0.063 DBMET01974 | DBMET01974 | |
| 0.076 | 0.085 | 0.151 | MAO A inhibitor | 0.151 0.041 DB00316 | DB00316 | |
| 0.116 | 0.125 | 0.322 | Hexokinase inhibitor | 0.322 0.009 DB00316 | DB00316 | |
| 0.046 | 0.055 | 0.059 | Vanilloid 2 antagonist | 0.055 0.03 DB00316 0.059 0.024 DBMET01974 | DBMET01974 | |
| 0.061 | 0.072 | 0.149 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.141 0.021 DB00316 0.149 0.019 DBMET01974 | DBMET01974 | |
| 0.029 | 0.04 | 0.043 | Factor XIIIa inhibitor | 0.043 0.021 DBMET01974 | DBMET01974 | |
| 0.193 | 0.204 | 0.324 | Immunosuppressant | 0.324 0.101 DBMET01974 | DBMET01974 | |
| 0.051 | 0.063 | 0.067 | Leukotriene C antagonist | 0.065 0.02 DB00316 0.067 0.017 DBMET01974 | DBMET01974 | |
| 0.1 | 0.112 | 0.116 | Nav1.2 sodium channel blocker | 0.111 0.095 DB00316 0.116 0.088 DBMET01974 | DBMET01974 | |
| 0.027 | 0.039 | 0.034 | Carnitine palmitoyltransferase inhibitor | 0.034 0.023 DB00316 | DB00316 | |
| 0.067 | 0.08 | 0.129 | GABA B receptor agonist | 0.129 0.005 DB00316 0.107 0.012 DBMET01974 | DB00316 | |
| 0.019 | 0.033 | 0.027 | Melatonin antagonist | 0.027 0.022 DB00316 | DB00316 | |
| 0.207 | 0.22 | 0.421 | DNA polymerase beta inhibitor | 0.421 0.111 DB00316 | DB00316 | |
| 0.041 | 0.054 | 0.066 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.017 DB00316 0.065 0.018 DBMET01974 | DB00316 | |
| 0.027 | 0.04 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.023 DB00316 | DB00316 | |
| 0.072 | 0.088 | 0.084 | Thioredoxin reductase inhibitor | 0.084 0.051 DB00316 | DB00316 | |
| 0.045 | 0.06 | 0.221 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.066 0.029 DB00316 0.221 0.006 DBMET01974 | DBMET01974 | |
| 0.123 | 0.139 | 0.131 | Tumour necrosis factor antagonist | 0.131 0.125 DB00316 | DB00316 | |
| 0.075 | 0.091 | 0.114 | Hematopoietic | 0.088 0.054 DB00316 0.114 0.025 DBMET01974 | DBMET01974 | |
| 0.011 | 0.028 | 0.018 | Adenosine A2 receptor agonist | 0.018 0.009 DB00316 | DB00316 | |
| 0.046 | 0.064 | 0.075 | DNA helicase inhibitor | 0.067 0.02 DB00316 0.075 0.014 DBMET01974 | DBMET01974 | |
| 0.085 | 0.102 | 0.131 | Toll-Like receptor 4 antagonist | 0.131 0.034 DB00316 | DB00316 | |
| 0.063 | 0.082 | 0.16 | Keratolytic | 0.16 0.013 DB00316 0.11 0.025 DBMET01974 | DB00316 | |
| 0.06 | 0.079 | 0.106 | Analgesic, opioid | 0.106 0.028 DBMET01974 | DBMET01974 | |
| 0.019 | 0.037 | 0.052 | Lysophosphatidic acid receptor 1 agonist | 0.052 0.004 DBMET01974 | DBMET01974 | |
| 0.029 | 0.048 | 0.036 | Delayed rectifier potassium channel blocker | 0.036 0.029 DBMET01974 | DBMET01974 | |
| 0.166 | 0.186 | 0.217 | Prostaglandin dehydrogenase inhibitor | 0.217 0.146 DB00316 | DB00316 | |
| 0.053 | 0.074 | 0.108 | Interferon inducer | 0.061 0.052 DB00316 0.108 0.01 DBMET01974 | DBMET01974 | |
| 0.009 | 0.03 | 0.019 | 5-Alpha-reductase 1 inhibitor | 0.019 0.011 DBMET01974 | DBMET01974 | |
| 0.196 | 0.218 | 0.403 | 15-Lipoxygenase inhibitor | 0.403 0.073 DB00316 0.25 0.164 DBMET01974 | DB00316 | |
| 0.078 | 0.1 | 0.144 | Glutamate release inhibitor | 0.094 0.054 DB00316 0.144 0.011 DBMET01974 | DBMET01974 | |
| 0.004 | 0.028 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 DB00316 0.008 0.006 DBMET01974 | DB00316 | |
| 0.046 | 0.07 | 0.094 | Cyclin D1 inhibitor | 0.094 0.01 DB00316 | DB00316 | |
| 0.031 | 0.055 | 0.074 | Carbonic anhydrase XII inhibitor | 0.074 0.028 DB00316 | DB00316 | |
| 0.014 | 0.039 | 0.02 | Potassium channel (Inward rectifier) 11 blocker | 0.02 0.009 DB00316 | DB00316 | |
| 0.138 | 0.163 | 0.176 | Histone acetyltransferase inhibitor | 0.176 0.105 DB00316 0.153 0.135 DBMET01974 | DB00316 | |
| 0.011 | 0.036 | 0.03 | Vitamin D receptor agonist | 0.03 0.004 DBMET01974 | DBMET01974 | |
| 0.03 | 0.056 | 0.049 | Neurokinin 2 agonist | 0.049 0.019 DBMET01974 | DBMET01974 | |
| 0.032 | 0.058 | 0.044 | Leukotriene C4 antagonist | 0.042 0.019 DB00316 0.044 0.017 DBMET01974 | DBMET01974 | |
| 0.117 | 0.143 | 0.194 | Interferon gamma antagonist | 0.194 0.043 DB00316 0.181 0.05 DBMET01974 | DB00316 | |
| 0.114 | 0.14 | 0.17 | Neuropeptide Y1 antagonist | 0.17 0.039 DB00316 | DB00316 | |
| 0.029 | 0.056 | 0.063 | Glutamate (mGluR8) agonist | 0.056 0.008 DB00316 0.063 0.006 DBMET01974 | DBMET01974 | |
| 0.025 | 0.052 | 0.04 | Opioid delta receptor agonist | 0.04 0.019 DBMET01974 | DBMET01974 | |
| 0.112 | 0.139 | 0.213 | Arachidonic acid antagonist | 0.191 0.041 DB00316 0.213 0.022 DBMET01974 | DBMET01974 | |
| 0.119 | 0.147 | 0.152 | Antipruritic | 0.152 0.092 DBMET01974 | DBMET01974 | |
| 0.135 | 0.162 | 0.292 | Neurotrophic factor enhancer | 0.292 0.02 DB00316 0.223 0.057 DBMET01974 | DB00316 | |
| 0.012 | 0.04 | 0.026 | 5-Alpha-reductase 2 inhibitor | 0.026 0.01 DBMET01974 | DBMET01974 | |
| 0.033 | 0.061 | 0.069 | AICAR transformylase inhibitor | 0.069 0.01 DB00316 0.053 0.019 DBMET01974 | DB00316 | |
| 0.072 | 0.101 | 0.113 | Granulocyte macrophage colony stimulating factor agonist | 0.111 0.022 DB00316 0.113 0.021 DBMET01974 | DBMET01974 | |
| 0.084 | 0.112 | 0.293 | Cholesterol synthesis inhibitor | 0.098 0.09 DB00316 0.293 0.012 DBMET01974 | DBMET01974 | |
| 0.013 | 0.043 | 0.02 | Caspase 8 inhibitor | 0.02 0.013 DB00316 0.02 0.013 DBMET01974 | DBMET01974 | |
| 0.014 | 0.044 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.01 DB00316 | DB00316 | |
| 0.09 | 0.12 | 0.227 | M17 leucyl aminopeptidase inhibitor | 0.227 0.025 DB00316 | DB00316 | |
| 0.006 | 0.036 | 0.031 | Lysophosphatidic acid receptor 3 agonist | 0.031 0.004 DBMET01974 | DBMET01974 | |
| 0.014 | 0.044 | 0.025 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DB00316 0.025 0.004 DBMET01974 | DBMET01974 | |
| 0.058 | 0.089 | 0.089 | Metalloproteinase-9 inhibitor | 0.073 0.051 DB00316 0.089 0.038 DBMET01974 | DBMET01974 | |
| 0.038 | 0.07 | 0.061 | CC chemokine receptor 2B antagonist | 0.061 0.018 DBMET01974 | DBMET01974 | |
| 0.076 | 0.108 | 0.179 | Protein kinase (CK2) alpha inhibitor | 0.179 0.029 DB00316 | DB00316 | |
| 0.013 | 0.045 | 0.048 | NMDA receptor glycine site antagonist | 0.048 0.006 DB00316 | DB00316 | |
| 0.019 | 0.051 | 0.05 | Peptide deformylase inhibitor | 0.05 0.01 DBMET01974 | DBMET01974 | |
| 0.096 | 0.128 | 0.187 | Histone deacetylase SIRT1 inhibitor | 0.187 0.036 DB00316 | DB00316 | |
| 0.027 | 0.061 | 0.122 | Carbonic anhydrase VII inhibitor | 0.122 0.008 DB00316 | DB00316 | |
| 0.042 | 0.076 | 0.061 | Epithelial sodium channel blocker | 0.051 0.046 DB00316 0.061 0.028 DBMET01974 | DBMET01974 | |
| 0.138 | 0.171 | 0.202 | Growth factor agonist | 0.202 0.061 DB00316 | DB00316 | |
| 0.038 | 0.072 | 0.059 | HIV-1 integrase (Strand Transfer) inhibitor | 0.059 0.042 DB00316 | DB00316 | |
| 0.02 | 0.054 | 0.037 | Purinergic P2Y15 antagonist | 0.036 0.009 DB00316 0.037 0.009 DBMET01974 | DBMET01974 | |
| 0.041 | 0.075 | 0.051 | Factor III inhibitor | 0.051 0.031 DB00316 | DB00316 | |
| 0.094 | 0.128 | 0.165 | Transcription factor STAT6 inhibitor | 0.165 0.014 DB00316 | DB00316 | |
| 0.119 | 0.154 | 0.263 | MAP kinase kinase 2 inhibitor | 0.263 0.048 DB00316 0.15 0.122 DBMET01974 | DB00316 | |
| 0.037 | 0.073 | 0.07 | Bombesin 2 receptor antagonist | 0.046 0.039 DB00316 0.07 0.019 DBMET01974 | DBMET01974 | |
| 0.032 | 0.068 | 0.048 | Adenosine A2b receptor antagonist | 0.048 0.035 DB00316 | DB00316 | |
| 0.015 | 0.051 | 0.104 | Lysine carboxypeptidase inhibitor | 0.104 0.004 DBMET01974 | DBMET01974 | |
| 0.027 | 0.063 | 0.081 | Phosphorylase inhibitor | 0.049 0.031 DB00316 0.081 0.017 DBMET01974 | DBMET01974 | |
| 0.017 | 0.054 | 0.032 | Vanilloid 2 agonist | 0.032 0.007 DBMET01974 | DBMET01974 | |
| 0.02 | 0.058 | 0.068 | Phosphoglycerate kinase inhibitor | 0.039 0.02 DB00316 0.068 0.01 DBMET01974 | DBMET01974 | |
| 0.039 | 0.077 | 0.222 | Biliverdin reductase inhibitor | 0.107 0.017 DB00316 0.222 0.005 DBMET01974 | DBMET01974 | |
| 0.066 | 0.104 | 0.104 | Caspase 7 inhibitor | 0.104 0.025 DBMET01974 | DBMET01974 | |
| 0.031 | 0.07 | 0.106 | Carbonic anhydrase XIV inhibitor | 0.106 0.009 DB00316 0.044 0.041 DBMET01974 | DB00316 | |
| 0.011 | 0.05 | 0.067 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.067 0.006 DBMET01974 | DBMET01974 | |
| 0.013 | 0.053 | 0.144 | Glycine transporter 1 inhibitor | 0.144 0.004 DBMET01974 | DBMET01974 | |
| 0.026 | 0.065 | 0.072 | Carbonic anhydrase IX inhibitor | 0.072 0.031 DB00316 | DB00316 | |
| 0.016 | 0.056 | 0.027 | Caspase 2 inhibitor | 0.027 0.026 DB00316 | DB00316 | |
| 0.029 | 0.069 | 0.101 | Neurotensin receptor antagonist | 0.101 0.014 DBMET01974 | DBMET01974 | |
| 0.025 | 0.066 | 0.072 | Glycine transporter 2 inhibitor | 0.063 0.024 DB00316 0.072 0.02 DBMET01974 | DBMET01974 | |
| 0.055 | 0.096 | 0.099 | Adenosine A3 receptor antagonist | 0.099 0.027 DB00316 | DB00316 | |
| 0.027 | 0.07 | 0.085 | Ribonucleoside-diphosphate reductase inhibitor | 0.07 0.029 DB00316 0.085 0.023 DBMET01974 | DBMET01974 | |
| 0.054 | 0.097 | 0.12 | Calcium antagonist | 0.12 0.035 DBMET01974 | DBMET01974 | |
| 0.005 | 0.048 | 0.012 | Immunosuppressant Cyclosporine-like | 0.012 0.007 DBMET01974 | DBMET01974 | |
| 0.074 | 0.117 | 0.109 | Nav1.1 sodium channel blocker | 0.109 0.057 DBMET01974 | DBMET01974 | |
| 0.113 | 0.156 | 0.215 | Amyloid beta precursor protein antagonist | 0.215 0.048 DB00316 | DB00316 | |
| 0.128 | 0.172 | 0.398 | Platelet antagonist | 0.398 0.027 DBMET01974 | DBMET01974 | |
| 0.027 | 0.071 | 0.087 | Ribonucleotide reductase inhibitor | 0.071 0.031 DB00316 0.087 0.024 DBMET01974 | DBMET01974 | |
| 0.056 | 0.1 | 0.095 | Bcr-Abl kinase inhibitor | 0.095 0.045 DB00316 | DB00316 | |
| 0.062 | 0.107 | 0.104 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.104 0.035 DB00316 | DB00316 | |
| 0.047 | 0.092 | 0.194 | Carbonic anhydrase XIII inhibitor | 0.194 0.015 DB00316 0.098 0.039 DBMET01974 | DB00316 | |
| 0.083 | 0.13 | 0.153 | Photosensitizer | 0.138 0.039 DB00316 0.153 0.029 DBMET01974 | DBMET01974 | |
| 0.033 | 0.08 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 DB00316 0.104 0.004 DBMET01974 | DBMET01974 | |
| 0.038 | 0.085 | 0.074 | CD45 antagonist | 0.074 0.014 DB00316 0.053 0.029 DBMET01974 | DB00316 | |
| 0.026 | 0.073 | 0.084 | Antimetabolite | 0.084 0.019 DBMET01974 | DBMET01974 | |
| 0.032 | 0.08 | 0.081 | Maillard reaction inhibitor | 0.081 0.024 DB00316 | DB00316 | |
| 0.039 | 0.087 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 DB00316 0.055 0.046 DBMET01974 | DB00316 | |
| 0.046 | 0.095 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.036 DB00316 0.058 0.057 DBMET01974 | DB00316 | |
| 0.017 | 0.066 | 0.052 | 5-Alpha-reductase inhibitor | 0.052 0.018 DBMET01974 | DBMET01974 | |
| 0.058 | 0.107 | 0.133 | NMDA receptor antagonist | 0.133 0.03 DB00316 0.109 0.042 DBMET01974 | DB00316 | |
| 0.107 | 0.159 | 0.2 | Adenylate cyclase stimulant | 0.177 0.028 DB00316 0.2 0.013 DBMET01974 | DBMET01974 | |
| 0.086 | 0.138 | 0.151 | Interleukin 8 antagonist | 0.151 0.033 DB00316 0.131 0.049 DBMET01974 | DB00316 | |
| 0.01 | 0.062 | 0.033 | Methionyl aminopeptidase 2 inhibitor | 0.033 0.012 DBMET01974 | DBMET01974 | |
| 0.021 | 0.073 | 0.054 | Toll-Like receptor 2 agonist | 0.038 0.031 DB00316 0.054 0.022 DBMET01974 | DBMET01974 | |
| 0.183 | 0.235 | 0.482 | Alpha-glucosidase inhibitor | 0.482 0.086 DB00316 | DB00316 | |
| 0.056 | 0.109 | 0.209 | Carbonic anhydrase VI inhibitor | 0.209 0.012 DB00316 0.11 0.034 DBMET01974 | DB00316 | |
| 0.017 | 0.07 | 0.139 | Fumarate hydratase inhibitor | 0.037 0.021 DB00316 0.139 0.004 DBMET01974 | DBMET01974 | |
| 0.022 | 0.077 | 0.044 | Glutamate (mGluR3) agonist | 0.042 0.008 DB00316 0.044 0.007 DBMET01974 | DBMET01974 | |
| 0.026 | 0.081 | 0.045 | Histone deacetylase 9 inhibitor | 0.045 0.02 DB00316 | DB00316 | |
| 0.052 | 0.107 | 0.079 | Exportin-1 inhibitor | 0.079 0.027 DBMET01974 | DBMET01974 | |
| 0.025 | 0.081 | 0.138 | Carbonic anhydrase VB inhibitor | 0.138 0.01 DB00316 0.065 0.031 DBMET01974 | DB00316 | |
| 0.022 | 0.078 | 0.072 | Dopamine D5 agonist | 0.072 0.008 DB00316 0.051 0.016 DBMET01974 | DB00316 | |
| 0.122 | 0.179 | 0.156 | Focal adhesion kinase 2 inhibitor | 0.156 0.122 DB00316 | DB00316 | |
| 0.035 | 0.092 | 0.228 | Carbamoyl phosphate synthetase inhibitor | 0.084 0.027 DB00316 0.228 0.006 DBMET01974 | DBMET01974 | |
| 0.092 | 0.149 | 0.168 | Sphingosine 1-phosphate receptor 4 antagonist | 0.168 0.02 DB00316 0.114 0.085 DBMET01974 | DB00316 | |
| 0.027 | 0.085 | 0.073 | Thymidine kinase inhibitor | 0.073 0.01 DBMET01974 | DBMET01974 | |
| 0.121 | 0.179 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.155 0.031 DB00316 0.18 0.007 DBMET01974 | DBMET01974 | |
| 0.027 | 0.085 | 0.073 | Dihydroorotase inhibitor | 0.073 0.01 DB00316 | DB00316 | |
| 0.017 | 0.076 | 0.03 | Cyclophilin A inhibitor | 0.03 0.022 DB00316 | DB00316 | |
| 0.049 | 0.108 | 0.142 | Phospholipase D inhibitor | 0.142 0.004 DBMET01974 | DBMET01974 | |
| 0.114 | 0.173 | 0.201 | I kappa B kinase epsilon inhibitor | 0.201 0.07 DB00316 | DB00316 | |
| 0.1 | 0.159 | 0.314 | Angiogenesis stimulant | 0.22 0.084 DB00316 0.314 0.044 DBMET01974 | DBMET01974 | |
| 0.119 | 0.178 | 0.24 | Platelet aggregation inhibitor | 0.24 0.057 DBMET01974 | DBMET01974 | |
| 0.03 | 0.09 | 0.058 | Collagenase inhibitor | 0.058 0.018 DBMET01974 | DBMET01974 | |
| 0.015 | 0.075 | 0.033 | Calcium-sensing receptor agonist | 0.033 0.011 DBMET01974 | DBMET01974 | |
| 0.033 | 0.094 | 0.05 | HCV NS3/NS4A protease inhibitor | 0.05 0.033 DBMET01974 | DBMET01974 | |
| 0.048 | 0.109 | 0.071 | Trypsin inhibitor | 0.071 0.032 DBMET01974 | DBMET01974 | |
| 0.014 | 0.075 | 0.041 | Trypsin I inhibitor | 0.041 0.017 DBMET01974 | DBMET01974 | |
| 0.033 | 0.095 | 0.075 | Leukotriene B4 antagonist | 0.075 0.017 DBMET01974 | DBMET01974 | |
| 0.182 | 0.245 | 0.351 | Transcription factor inhibitor | 0.351 0.13 DB00316 | DB00316 | |
| 0.019 | 0.082 | 0.06 | Inosine monophosphate dehydrogenase inhibitor | 0.06 0.01 DB00316 | DB00316 | |
| 0.08 | 0.144 | 0.116 | Cytokine production inhibitor | 0.116 0.094 DB00316 | DB00316 | |
| 0.032 | 0.096 | 0.112 | NMDA 2C receptor antagonist | 0.112 0.012 DB00316 0.088 0.021 DBMET01974 | DB00316 | |
| 0.067 | 0.132 | 0.108 | Nitric-oxide synthase inhibitor | 0.108 0.049 DBMET01974 | DBMET01974 | |
| 0.052 | 0.118 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.048 DBMET01974 | DBMET01974 | |
| 0.05 | 0.116 | 0.134 | GABA aminotransferase inhibitor | 0.134 0.011 DB00316 0.118 0.017 DBMET01974 | DB00316 | |
| 0.12 | 0.187 | 0.177 | Heat shock protein 70 antagonist | 0.177 0.013 DB00316 0.145 0.057 DBMET01974 | DB00316 | |
| 0.049 | 0.116 | 0.185 | Ornithine decarboxylase inhibitor | 0.079 0.068 DB00316 0.185 0.005 DBMET01974 | DBMET01974 | |
| 0.007 | 0.074 | 0.019 | Thromboxane A2 agonist | 0.015 0.012 DB00316 0.019 0.006 DBMET01974 | DBMET01974 | |
| 0.061 | 0.129 | 0.246 | Creatine kinase inhibitor | 0.246 0.006 DB00316 0.216 0.008 DBMET01974 | DB00316 | |
| 0.022 | 0.089 | 0.078 | CDK5/p25 inhibitor | 0.078 0.009 DB00316 | DB00316 | |
| 0.019 | 0.087 | 0.04 | Histone deacetylase 7 inhibitor | 0.04 0.023 DB00316 | DB00316 | |
| 0.061 | 0.13 | 0.115 | MAP kinase kinase 7 inhibitor | 0.115 0.005 DB00316 0.083 0.039 DBMET01974 | DB00316 | |
| 0.008 | 0.077 | 0.036 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.036 0.01 DB00316 | DB00316 | |
| 0.011 | 0.08 | 0.023 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 DB00316 | DB00316 | |
| 0.029 | 0.099 | 0.043 | VCAM-1 antagonist | 0.043 0.017 DBMET01974 | DBMET01974 | |
| 0.029 | 0.099 | 0.043 | VCAM antagonist | 0.043 0.018 DBMET01974 | DBMET01974 | |
| 0.137 | 0.207 | 0.489 | 5 Hydroxytryptamine release stimulant | 0.327 0.062 DB00316 0.489 0.029 DBMET01974 | DBMET01974 | |
| 0.01 | 0.081 | 0.084 | AMPA 3 receptor antagonist | 0.084 0.004 DBMET01974 | DBMET01974 | |
| 0.02 | 0.092 | 0.048 | Carboxypeptidase B inhibitor | 0.048 0.007 DBMET01974 | DBMET01974 | |
| 0.028 | 0.101 | 0.214 | Argininosuccinate synthase inhibitor | 0.072 0.029 DB00316 0.214 0.007 DBMET01974 | DBMET01974 | |
| 0.022 | 0.095 | 0.203 | Ornithine carbamoyltransferase inhibitor | 0.048 0.042 DB00316 0.203 0.007 DBMET01974 | DBMET01974 | |
| 0.093 | 0.166 | 0.266 | Mannose-6-phosphate isomerase inhibitor | 0.154 0.061 DB00316 0.266 0.009 DBMET01974 | DBMET01974 | |
| 0.038 | 0.111 | 0.117 | Purinergic P2X1 antagonist | 0.117 0.012 DB00316 0.095 0.018 DBMET01974 | DB00316 | |
| 0.012 | 0.085 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 DBMET01974 | DBMET01974 | |
| 0.092 | 0.166 | 0.14 | DNA repair enzyme inhibitor | 0.14 0.042 DB00316 0.121 0.071 DBMET01974 | DB00316 | |
| 0.042 | 0.115 | 0.254 | Glutamate decarboxylase inhibitor | 0.138 0.015 DB00316 0.254 0.004 DBMET01974 | DBMET01974 | |
| 0.038 | 0.112 | 0.095 | Angiotensin-converting enzyme inhibitor | 0.095 0.009 DBMET01974 | DBMET01974 | |
| 0.009 | 0.084 | 0.05 | Cyclin E2 inhibitor | 0.05 0.009 DB00316 | DB00316 | |
| 0.003 | 0.078 | 0.01 | Thromboxane agonist | 0.01 0.009 DBMET01974 | DBMET01974 | |
| 0.004 | 0.079 | 0.009 | Free fatty acid receptor 2 antagonist | 0.009 0.005 DBMET01974 | DBMET01974 | |
| 0.045 | 0.121 | 0.07 | Calcium channel L-type blocker | 0.07 0.052 DBMET01974 | DBMET01974 | |
| 0.049 | 0.125 | 0.092 | Myeloperoxidase inhibitor | 0.092 0.046 DB00316 0.086 0.055 DBMET01974 | DB00316 | |
| 0.076 | 0.152 | 0.112 | CDC-like kinase 3 inhibitor | 0.112 0.055 DB00316 | DB00316 | |
| 0.022 | 0.098 | 0.049 | Matrix metalloproteinase 1 inhibitor | 0.049 0.039 DBMET01974 | DBMET01974 | |
| 0.035 | 0.112 | 0.08 | Leukotriene antagonist | 0.08 0.032 DBMET01974 | DBMET01974 | |
| 0.041 | 0.117 | 0.066 | Adenine nucleotide translocase inhibitor | 0.066 0.019 DB00316 0.065 0.02 DBMET01974 | DB00316 | |
| 0.003 | 0.08 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.006 DBMET01974 | DBMET01974 | |
| 0.105 | 0.183 | 0.161 | Pregnane X receptor agonist | 0.161 0.036 DB00316 0.136 0.083 DBMET01974 | DB00316 | |
| 0.056 | 0.133 | 0.086 | Sphingosine 1-phosphate receptor antagonist | 0.086 0.035 DB00316 0.085 0.037 DBMET01974 | DB00316 | |
| 0.056 | 0.134 | 0.177 | HIV-1 integrase (Overall Integration) inhibitor | 0.169 0.019 DB00316 0.177 0.017 DBMET01974 | DBMET01974 | |
| 0.054 | 0.132 | 0.09 | Viral attachment inhibitor | 0.09 0.033 DBMET01974 | DBMET01974 | |
| 0.011 | 0.089 | 0.034 | Sirtuin 2 inhibitor | 0.034 0.022 DB00316 | DB00316 | |
| 0.007 | 0.085 | 0.025 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.025 0.01 DB00316 | DB00316 | |
| 0.022 | 0.101 | 0.056 | Opioid agonist | 0.056 0.033 DBMET01974 | DBMET01974 | |
| 0.041 | 0.12 | 0.125 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.125 0.005 DB00316 | DB00316 | |
| 0.172 | 0.252 | 0.41 | DNA directed DNA polymerase inhibitor | 0.41 0.111 DB00316 | DB00316 | |
| 0.034 | 0.114 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.073 0.022 DB00316 0.059 0.039 DBMET01974 | DB00316 | |
| 0.024 | 0.104 | 0.047 | Nerve growth factor antagonist | 0.043 0.03 DB00316 0.047 0.022 DBMET01974 | DBMET01974 | |
| 0.02 | 0.101 | 0.077 | Adenosine deaminase inhibitor | 0.047 0.033 DB00316 0.077 0.01 DBMET01974 | DBMET01974 | |
| 0.021 | 0.103 | 0.08 | Geranyltranstransferase inhibitor | 0.04 0.037 DB00316 0.08 0.005 DBMET01974 | DBMET01974 | |
| 0.177 | 0.259 | 0.318 | Antibacterial | 0.318 0.122 DB00316 0.303 0.133 DBMET01974 | DB00316 | |
| 0.015 | 0.097 | 0.032 | Lysophosphatidic acid 2 receptor antagonist | 0.031 0.02 DB00316 0.032 0.019 DBMET01974 | DBMET01974 | |
| 0.03 | 0.113 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 DB00316 | DB00316 | |
| 0.086 | 0.169 | 0.169 | Acetylcholine M1 receptor antagonist | 0.169 0.059 DBMET01974 | DBMET01974 | |
| 0.005 | 0.088 | 0.082 | AMPA 1 receptor antagonist | 0.082 0.007 DBMET01974 | DBMET01974 | |
| 0.031 | 0.115 | 0.064 | Potassium channel (Inward rectifier) activator | 0.064 0.016 DB00316 | DB00316 | |
| 0.007 | 0.091 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET01974 | DBMET01974 | |
| 0.095 | 0.179 | 0.18 | Growth hormone agonist | 0.18 0.068 DB00316 0.163 0.077 DBMET01974 | DB00316 | |
| 0.022 | 0.107 | 0.084 | NMDA receptor subunit 3B antagonist | 0.084 0.013 DB00316 0.078 0.014 DBMET01974 | DB00316 | |
| 0.018 | 0.103 | 0.088 | NMDA 2A receptor antagonist | 0.081 0.019 DB00316 0.088 0.017 DBMET01974 | DBMET01974 | |
| 0.006 | 0.092 | 0.023 | Thyroid hormone alpha antagonist | 0.023 0.006 DBMET01974 | DBMET01974 | |
| 0.021 | 0.106 | 0.208 | Aldose reductase inhibitor | 0.208 0.007 DBMET01974 | DBMET01974 | |
| 0.03 | 0.116 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.049 0.034 DB00316 0.059 0.016 DBMET01974 | DBMET01974 | |
| 0.045 | 0.131 | 0.082 | Metalloproteinase-2 inhibitor | 0.075 0.058 DB00316 0.082 0.051 DBMET01974 | DBMET01974 | |
| 0.07 | 0.156 | 0.108 | Phosphodiesterase 6D inhibitor | 0.108 0.039 DB00316 0.09 0.075 DBMET01974 | DB00316 | |
| 0.028 | 0.115 | 0.066 | Selectin antagonist | 0.066 0.045 DB00316 0.063 0.047 DBMET01974 | DB00316 | |
| 0.014 | 0.102 | 0.038 | Calcitonin receptor agonist | 0.038 0.021 DBMET01974 | DBMET01974 | |
| 0.035 | 0.124 | 0.269 | Histidine decarboxylase inhibitor | 0.22 0.011 DB00316 0.269 0.008 DBMET01974 | DBMET01974 | |
| 0.099 | 0.189 | 0.19 | Melanin inhibitor | 0.19 0.045 DB00316 0.146 0.087 DBMET01974 | DB00316 | |
| 0.064 | 0.153 | 0.126 | MAP kinase kinase 1 inhibitor | 0.126 0.029 DB00316 | DB00316 | |
| 0.086 | 0.176 | 0.248 | Diuretic | 0.13 0.094 DB00316 0.248 0.031 DBMET01974 | DBMET01974 | |
| 0.032 | 0.123 | 0.067 | Matrix metalloproteinase inhibitor | 0.067 0.047 DBMET01974 | DBMET01974 | |
| 0.043 | 0.133 | 0.091 | Glutamate (mGluR7) antagonist | 0.081 0.026 DB00316 0.091 0.017 DBMET01974 | DBMET01974 | |
| 0.025 | 0.117 | 0.049 | CC chemokine 4 receptor antagonist | 0.049 0.029 DBMET01974 | DBMET01974 | |
| 0.137 | 0.229 | 0.376 | 12-Lipoxygenase inhibitor | 0.376 0.046 DB00316 | DB00316 | |
| 0.013 | 0.105 | 0.03 | ICAM 1 antagonist | 0.03 0.007 DBMET01974 | DBMET01974 | |
| 0.029 | 0.122 | 0.218 | Phosphofructokinase-1 inhibitor | 0.102 0.031 DB00316 0.218 0.009 DBMET01974 | DBMET01974 | |
| 0.021 | 0.115 | 0.049 | Fructose-1,6-bisphosphatase inhibitor | 0.049 0.026 DB00316 | DB00316 | |
| 0.035 | 0.13 | 0.071 | Histone deacetylase inhibitor | 0.071 0.039 DB00316 | DB00316 | |
| 0.048 | 0.143 | 0.073 | Prolactin release inhibitor | 0.073 0.018 DBMET01974 | DBMET01974 | |
| 0.091 | 0.186 | 0.135 | Aurora-C kinase inhibitor | 0.135 0.074 DB00316 | DB00316 | |
| 0.024 | 0.119 | 0.074 | Neutrophil collagenase inhibitor | 0.074 0.036 DBMET01974 | DBMET01974 | |
| 0.006 | 0.102 | 0.042 | Nicotinic acid receptor 1 antagonist | 0.042 0.003 DB00316 | DB00316 | |
| 0.026 | 0.122 | 0.073 | Kainate receptor agonist | 0.043 0.024 DB00316 0.073 0.004 DBMET01974 | DBMET01974 | |
| 0.032 | 0.129 | 0.084 | HIV-1 integrase (3'-Processing) inhibitor | 0.084 0.032 DB00316 | DB00316 | |
| 0.046 | 0.143 | 0.145 | Protein kinase (CK2) inhibitor | 0.145 0.035 DB00316 | DB00316 | |
| 0.025 | 0.123 | 0.061 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.061 0.007 DB00316 0.054 0.011 DBMET01974 | DB00316 | |
| 0.004 | 0.101 | 0.025 | Peroxisome proliferator-activated receptor alpha antagonist | 0.025 0.013 DBMET01974 | DBMET01974 | |
| 0.01 | 0.107 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.013 DB00316 0.018 0.017 DBMET01974 | DB00316 | |
| 0.016 | 0.115 | 0.051 | Oxytocin agonist | 0.051 0.023 DB00316 0.049 0.024 DBMET01974 | DB00316 | |
| 0.014 | 0.114 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.029 DBMET01974 | DBMET01974 | |
| 0.063 | 0.163 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.067 DB00316 | DB00316 | |
| 0.003 | 0.104 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.014 0.01 DBMET01974 | DBMET01974 | |
| 0.014 | 0.116 | 0.087 | NMDA receptor subunit 3A antagonist | 0.057 0.018 DB00316 0.087 0.01 DBMET01974 | DBMET01974 | |
| 0.099 | 0.201 | 0.174 | Interleukin 6 antagonist | 0.142 0.101 DB00316 0.174 0.061 DBMET01974 | DBMET01974 | |
| 0.013 | 0.116 | 0.039 | Glutamate (mGluR1) agonist | 0.039 0.006 DBMET01974 | DBMET01974 | |
| 0.041 | 0.143 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 DB00316 | DB00316 | |
| 0.029 | 0.132 | 0.068 | CXC chemokine 1 receptor antagonist | 0.068 0.014 DB00316 | DB00316 | |
| 0.008 | 0.111 | 0.095 | GP IIb/IIIa receptor antagonist | 0.095 0.019 DBMET01974 | DBMET01974 | |
| 0.065 | 0.169 | 0.138 | Interleukin 12 antagonist | 0.138 0.017 DB00316 | DB00316 | |
| 0.06 | 0.164 | 0.126 | Acetylcholine muscarinic antagonist | 0.126 0.061 DBMET01974 | DBMET01974 | |
| 0.012 | 0.116 | 0.03 | NMDA 2D receptor antagonist | 0.03 0.015 DBMET01974 | DBMET01974 | |
| 0.019 | 0.124 | 0.078 | Thymidylate synthase inhibitor | 0.078 0.008 DBMET01974 | DBMET01974 | |
| 0.045 | 0.151 | 0.114 | Glutamate (mGluR6) antagonist | 0.073 0.035 DB00316 0.114 0.006 DBMET01974 | DBMET01974 | |
| 0.014 | 0.12 | 0.051 | Purinergic P2Y antagonist | 0.051 0.026 DBMET01974 | DBMET01974 | |
| 0.007 | 0.113 | 0.021 | Telomerase stimulant | 0.021 0.007 DBMET01974 | DBMET01974 | |
| 0.015 | 0.122 | 0.089 | Peroxisome proliferator-activated receptor alpha agonist | 0.089 0.015 DBMET01974 | DBMET01974 | |
| 0.013 | 0.121 | 0.053 | Estradiol 17 beta-dehydrogenase inhibitor | 0.053 0.023 DB00316 | DB00316 | |
| 0.026 | 0.134 | 0.078 | Purinergic P2X4 antagonist | 0.078 0.007 DB00316 | DB00316 | |
| 0.034 | 0.142 | 0.071 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.034 DB00316 0.071 0.018 DBMET01974 | DBMET01974 | |
| 0.01 | 0.118 | 0.029 | Prostaglandin F2 alpha agonist | 0.029 0.009 DBMET01974 | DBMET01974 | |
| 0.046 | 0.155 | 0.089 | Peroxisome proliferator-activated receptor gamma antagonist | 0.089 0.024 DBMET01974 | DBMET01974 | |
| 0.022 | 0.131 | 0.044 | Potassium channel Kv1.1 blocker | 0.044 0.018 DB00316 | DB00316 | |
| 0.022 | 0.132 | 0.051 | Glutamate (mGluR group III) agonist | 0.051 0.023 DB00316 | DB00316 | |
| 0.013 | 0.123 | 0.036 | Histone deacetylase class I inhibitor | 0.036 0.03 DB00316 | DB00316 | |
| 0.038 | 0.148 | 0.079 | Acetylcholine nicotinic antagonist | 0.079 0.055 DBMET01974 | DBMET01974 | |
| 0.045 | 0.155 | 0.179 | Glycine receptor agonist | 0.086 0.032 DB00316 0.179 0.005 DBMET01974 | DBMET01974 | |
| 0.081 | 0.192 | 0.2 | Cell wall synthesis inhibitor | 0.2 0.03 DB00316 0.186 0.037 DBMET01974 | DB00316 | |
| 0.01 | 0.121 | 0.043 | Liver X receptor beta antagonist | 0.043 0.011 DBMET01974 | DBMET01974 | |
| 0.01 | 0.121 | 0.031 | Nicotinic acid receptor 2 antagonist | 0.031 0.012 DB00316 0.026 0.019 DBMET01974 | DB00316 | |
| 0.017 | 0.129 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET01974 | DBMET01974 | |
| 0.004 | 0.116 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.012 DBMET01974 | DBMET01974 | |
| 0.003 | 0.116 | 0.014 | Angiotensin AT1B receptor antagonist | 0.014 0.009 DBMET01974 | DBMET01974 | |
| 0.014 | 0.127 | 0.054 | Glycine transporter inhibitor | 0.054 0.028 DBMET01974 | DBMET01974 | |
| 0.009 | 0.123 | 0.069 | Kainate receptor 2 antagonist | 0.069 0.009 DBMET01974 | DBMET01974 | |
| 0.087 | 0.201 | 0.137 | Thiol protease inhibitor | 0.13 0.097 DB00316 0.137 0.084 DBMET01974 | DBMET01974 | |
| 0.008 | 0.124 | 0.027 | Glucagon receptor antagonist | 0.027 0.023 DBMET01974 | DBMET01974 | |
| 0.015 | 0.132 | 0.053 | Beta tubulin antagonist | 0.053 0.044 DB00316 | DB00316 | |
| 0.018 | 0.136 | 0.075 | Xanthine dehydrogenase inhibitor | 0.062 0.037 DB00316 0.075 0.027 DBMET01974 | DBMET01974 | |
| 0.077 | 0.195 | 0.183 | Anticoagulant | 0.183 0.06 DBMET01974 | DBMET01974 | |
| 0.062 | 0.18 | 0.103 | Nav1.4 sodium channel blocker | 0.103 0.072 DB00316 | DB00316 | |
| 0.057 | 0.176 | 0.123 | Xanthine oxidase inhibitor | 0.123 0.046 DB00316 0.105 0.056 DBMET01974 | DB00316 | |
| 0.025 | 0.144 | 0.147 | Aconitate hydratase inhibitor | 0.051 0.036 DB00316 0.147 0.004 DBMET01974 | DBMET01974 | |
| 0.028 | 0.147 | 0.103 | Vanilloid antagonist | 0.103 0.034 DB00316 | DB00316 | |
| 0.027 | 0.146 | 0.047 | Cytokine production stimulant | 0.047 0.036 DBMET01974 | DBMET01974 | |
| 0.011 | 0.131 | 0.043 | Farnesoid X receptor agonist | 0.043 0.02 DBMET01974 | DBMET01974 | |
| 0.02 | 0.139 | 0.039 | Protein kinase (CK2) beta inhibitor | 0.039 0.013 DB00316 | DB00316 | |
| 0.009 | 0.129 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.013 DBMET01974 | DBMET01974 | |
| 0.031 | 0.152 | 0.084 | Sphingosine kinase inhibitor | 0.084 0.013 DB00316 | DB00316 | |
| 0.024 | 0.145 | 0.083 | Glucagon-like peptide 1 agonist | 0.083 0.033 DBMET01974 | DBMET01974 | |
| 0.008 | 0.13 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 DBMET01974 | DBMET01974 | |
| 0.028 | 0.15 | 0.148 | Sphingosine 1-phosphate receptor 4 agonist | 0.148 0.009 DBMET01974 | DBMET01974 | |
| 0.011 | 0.134 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.016 DBMET01974 | DBMET01974 | |
| 0.011 | 0.133 | 0.076 | Nicotinic acid receptor agonist | 0.076 0.007 DB00316 | DB00316 | |
| 0.007 | 0.131 | 0.016 | Thyroid hormone alpha agonist | 0.016 0.012 DBMET01974 | DBMET01974 | |
| 0.097 | 0.222 | 0.148 | Death-associated protein kinase 1 inhibitor | 0.148 0.042 DB00316 | DB00316 | |
| 0.084 | 0.21 | 0.205 | LIM domain kinase 1 inhibitor | 0.205 0.061 DB00316 | DB00316 | |
| 0.002 | 0.128 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 DB00316 | DB00316 | |
| 0.055 | 0.182 | 0.097 | Potassium channel (Voltage-sensitive) activator | 0.097 0.057 DB00316 | DB00316 | |
| 0.02 | 0.148 | 0.053 | Sphingosine kinase 1 inhibitor | 0.053 0.014 DB00316 | DB00316 | |
| 0.007 | 0.136 | 0.029 | Uridine phosphorylase inhibitor | 0.029 0.018 DBMET01974 | DBMET01974 | |
| 0.058 | 0.189 | 0.136 | Nav1.6 sodium channel blocker | 0.136 0.072 DBMET01974 | DBMET01974 | |
| 0.009 | 0.14 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 DB00316 | DB00316 | |
| 0.019 | 0.149 | 0.085 | AMPA 4 receptor antagonist | 0.085 0.006 DBMET01974 | DBMET01974 | |
| 0.021 | 0.153 | 0.053 | Adenylate cyclase 1 inhibitor | 0.053 0.023 DB00316 0.045 0.033 DBMET01974 | DB00316 | |
| 0.051 | 0.184 | 0.222 | Cystathionine beta-synthase inhibitor | 0.222 0.02 DB00316 0.192 0.027 DBMET01974 | DB00316 | |
| 0.012 | 0.146 | 0.026 | Integrin alpha2beta1 antagonist | 0.026 0.019 DBMET01974 | DBMET01974 | |
| 0.021 | 0.155 | 0.041 | Aggrecanase 1 inhibitor | 0.041 0.024 DBMET01974 | DBMET01974 | |
| 0.013 | 0.147 | 0.069 | Sphingosine 1-phosphate receptor 1 agonist | 0.069 0.009 DBMET01974 | DBMET01974 | |
| 0.016 | 0.151 | 0.061 | Erythropoietin receptor agonist | 0.061 0.017 DBMET01974 | DBMET01974 | |
| 0.017 | 0.152 | 0.036 | Integrin alpha2 antagonist | 0.036 0.027 DBMET01974 | DBMET01974 | |
| 0.052 | 0.187 | 0.111 | Bile acid receptor antagonist | 0.111 0.029 DB00316 0.111 0.029 DBMET01974 | DBMET01974 | |
| 0.007 | 0.142 | 0.028 | Glutamate (mGluR1a) agonist | 0.021 0.017 DB00316 0.028 0.01 DBMET01974 | DBMET01974 | |
| 0.017 | 0.152 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.028 DB00316 | DB00316 | |
| 0.003 | 0.138 | 0.017 | Integrin beta2 antagonist | 0.017 0.005 DBMET01974 | DBMET01974 | |
| 0.021 | 0.157 | 0.064 | Diacylglycerol O-acyltransferase inhibitor | 0.064 0.023 DBMET01974 | DBMET01974 | |
| 0.016 | 0.154 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.02 DBMET01974 | DBMET01974 | |
| 0.014 | 0.153 | 0.062 | Macrophage elastase inhibitor | 0.062 0.017 DBMET01974 | DBMET01974 | |
| 0.024 | 0.163 | 0.058 | Glutamate (mGluR4) antagonist | 0.058 0.015 DBMET01974 | DBMET01974 | |
| 0.011 | 0.15 | 0.105 | Retinoid X alpha receptor agonist | 0.105 0.005 DBMET01974 | DBMET01974 | |
| 0.01 | 0.149 | 0.031 | Retinoid X beta receptor antagonist | 0.031 0.004 DBMET01974 | DBMET01974 | |
| 0.009 | 0.149 | 0.088 | Kainate receptor antagonist | 0.088 0.009 DBMET01974 | DBMET01974 | |
| 0.017 | 0.157 | 0.047 | Retinoid X alpha receptor antagonist | 0.047 0.008 DBMET01974 | DBMET01974 | |
| 0.038 | 0.179 | 0.083 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.066 DB00316 0.083 0.032 DBMET01974 | DBMET01974 | |
| 0.023 | 0.163 | 0.218 | Peroxisome proliferator-activated receptor gamma agonist | 0.218 0.006 DBMET01974 | DBMET01974 | |
| 0.017 | 0.157 | 0.036 | Retinoic acid alpha receptor agonist | 0.036 0.035 DBMET01974 | DBMET01974 | |
| 0.03 | 0.171 | 0.084 | Histone deacetylase SIRT2 inhibitor | 0.084 0.042 DB00316 | DB00316 | |
| 0.05 | 0.192 | 0.165 | 5 Hydroxytryptamine 3A agonist | 0.165 0.028 DB00316 | DB00316 | |
| 0.002 | 0.145 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.005 DBMET01974 | DBMET01974 | |
| 0.031 | 0.174 | 0.064 | Sirtuin 1 inhibitor | 0.064 0.053 DB00316 | DB00316 | |
| 0.119 | 0.262 | 0.258 | Thioredoxin glutathione reductase inhibitor | 0.258 0.129 DB00316 | DB00316 | |
| 0.134 | 0.278 | 0.217 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.217 0.139 DB00316 | DB00316 | |
| 0.092 | 0.237 | 0.126 | MAP kinase 3 inhibitor | 0.126 0.117 DB00316 | DB00316 | |
| 0.014 | 0.159 | 0.04 | Integrin alpha5beta1 antagonist | 0.04 0.029 DBMET01974 | DBMET01974 | |
| 0.015 | 0.161 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.048 0.008 DBMET01974 | DBMET01974 | |
| 0.037 | 0.182 | 0.085 | Macrophage migration inhibitory factor inhibitor | 0.085 0.045 DB00316 0.075 0.058 DBMET01974 | DB00316 | |
| 0.017 | 0.163 | 0.081 | Dihydroorotate dehydrogenase inhibitor | 0.081 0.018 DB00316 | DB00316 | |
| 0.055 | 0.201 | 0.114 | Cholinergic antagonist | 0.114 0.079 DBMET01974 | DBMET01974 | |
| 0.062 | 0.209 | 0.164 | DOPA decarboxylase inhibitor | 0.164 0.015 DB00316 0.155 0.019 DBMET01974 | DB00316 | |
| 0.042 | 0.189 | 0.074 | Transcription factor RelA inhibitor | 0.074 0.024 DB00316 | DB00316 | |
| 0.03 | 0.178 | 0.069 | I kappa B kinase 2 inhibitor | 0.069 0.033 DB00316 | DB00316 | |
| 0.018 | 0.166 | 0.054 | Retinoid X receptor antagonist | 0.054 0.009 DBMET01974 | DBMET01974 | |
| 0.053 | 0.201 | 0.158 | Histone deacetylase class III inhibitor | 0.158 0.038 DB00316 | DB00316 | |
| 0.023 | 0.171 | 0.036 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.031 DBMET01974 | DBMET01974 | |
| 0.018 | 0.166 | 0.058 | Tryptophan 5 hydroxylase inhibitor | 0.058 0.004 DBMET01974 | DBMET01974 | |
| 0.017 | 0.166 | 0.063 | Opioid delta receptor antagonist | 0.063 0.044 DBMET01974 | DBMET01974 | |
| 0.031 | 0.18 | 0.07 | Cathepsin G inhibitor | 0.07 0.053 DBMET01974 | DBMET01974 | |
| 0.006 | 0.156 | 0.042 | Retinoid X gamma receptor agonist | 0.042 0.007 DBMET01974 | DBMET01974 | |
| 0.006 | 0.157 | 0.032 | CXC chemokine 2 receptor antagonist | 0.032 0.013 DB00316 | DB00316 | |
| 0.003 | 0.155 | 0.025 | Kainate receptor 1 antagonist | 0.025 0.012 DBMET01974 | DBMET01974 | |
| 0.053 | 0.206 | 0.107 | Acetylcholine antagonist | 0.107 0.083 DBMET01974 | DBMET01974 | |
| 0.013 | 0.167 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.01 DBMET01974 | DBMET01974 | |
| 0.007 | 0.163 | 0.019 | Integrin alphaVbeta1 antagonist | 0.019 0.014 DBMET01974 | DBMET01974 | |
| 0.008 | 0.165 | 0.079 | AMPA 2 receptor antagonist | 0.079 0.007 DBMET01974 | DBMET01974 | |
| 0.007 | 0.164 | 0.089 | Retinoid X receptor agonist | 0.089 0.006 DBMET01974 | DBMET01974 | |
| 0.006 | 0.164 | 0.036 | Leukotriene B4 receptor 1 antagonist | 0.036 0.014 DBMET01974 | DBMET01974 | |
| 0.042 | 0.201 | 0.075 | Neuropeptide Y antagonist | 0.075 0.067 DB00316 | DB00316 | |
| 0.048 | 0.207 | 0.093 | GABA receptor agonist | 0.093 0.086 DBMET01974 | DBMET01974 | |
| 0.004 | 0.163 | 0.019 | Integrin alpha4beta7 antagonist | 0.019 0.016 DBMET01974 | DBMET01974 | |
| 0.03 | 0.191 | 0.057 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.048 DBMET01974 | DBMET01974 | |
| 0.013 | 0.175 | 0.045 | Angiotensin II receptor antagonist | 0.045 0.01 DBMET01974 | DBMET01974 | |
| 0.01 | 0.174 | 0.08 | AMPA receptor antagonist | 0.08 0.017 DBMET01974 | DBMET01974 | |
| 0.05 | 0.215 | 0.134 | Beta glucuronidase inhibitor | 0.134 0.034 DB00316 | DB00316 | |
| 0.117 | 0.283 | 0.338 | DNA synthesis inhibitor | 0.251 0.066 DB00316 0.338 0.033 DBMET01974 | DBMET01974 | |
| 0.031 | 0.197 | 0.064 | Pregnane X receptor antagonist | 0.056 0.04 DB00316 0.064 0.023 DBMET01974 | DBMET01974 | |
| 0.104 | 0.27 | 0.373 | Hypoglycemic | 0.373 0.032 DBMET01974 | DBMET01974 | |
| 0.034 | 0.201 | 0.084 | I kappa B kinase inhibitor | 0.084 0.055 DB00316 | DB00316 | |
| 0.016 | 0.182 | 0.075 | Sphingosine 1-phosphate receptor agonist | 0.075 0.01 DBMET01974 | DBMET01974 | |
| 0.069 | 0.235 | 0.285 | Pyruvate kinase inhibitor | 0.285 0.051 DB00316 | DB00316 | |
| 0.014 | 0.182 | 0.047 | RNA-directed RNA polymerase inhibitor | 0.047 0.014 DBMET01974 | DBMET01974 | |
| 0.008 | 0.181 | 0.059 | Estrogen agonist | 0.059 0.031 DB00316 | DB00316 | |
| 0.044 | 0.217 | 0.089 | Vanilloid 4 agonist | 0.072 0.059 DB00316 0.089 0.027 DBMET01974 | DBMET01974 | |
| 0.104 | 0.277 | 0.256 | Lipoxygenase inhibitor | 0.256 0.096 DB00316 | DB00316 | |
| 0.006 | 0.181 | 0.034 | Prostaglandin agonist | 0.034 0.018 DBMET01974 | DBMET01974 | |
| 0.025 | 0.2 | 0.074 | Factor IXa inhibitor | 0.074 0.018 DB00316 | DB00316 | |
| 0.007 | 0.183 | 0.041 | Free fatty acid receptor 1 antagonist | 0.041 0.015 DBMET01974 | DBMET01974 | |
| 0.01 | 0.186 | 0.043 | Histone deacetylase 8 inhibitor | 0.043 0.027 DB00316 | DB00316 | |
| 0.009 | 0.185 | 0.036 | Nicotinic acid receptor 2 agonist | 0.036 0.024 DB00316 | DB00316 | |
| 0.01 | 0.186 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.004 DBMET01974 | DBMET01974 | |
| 0.004 | 0.181 | 0.032 | Prostaglandin EP2 agonist | 0.032 0.012 DBMET01974 | DBMET01974 | |
| 0.05 | 0.227 | 0.083 | ABCA1 expression enhancer | 0.083 0.08 DBMET01974 | DBMET01974 | |
| 0.015 | 0.193 | 0.026 | Hedgehog signaling activator | 0.026 0.023 DB00316 | DB00316 | |
| 0.012 | 0.19 | 0.056 | GABA uptake inhibitor | 0.056 0.012 DBMET01974 | DBMET01974 | |
| 0.005 | 0.185 | 0.035 | Squalene synthetase inhibitor | 0.035 0.02 DBMET01974 | DBMET01974 | |
| 0.021 | 0.201 | 0.094 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.094 0.012 DB00316 0.051 0.041 DBMET01974 | DB00316 | |
| 0.035 | 0.216 | 0.083 | Opioid antagonist | 0.077 0.074 DB00316 0.083 0.065 DBMET01974 | DBMET01974 | |
| 0.025 | 0.206 | 0.065 | Fatty acid synthase inhibitor | 0.065 0.03 DB00316 | DB00316 | |
| 0.011 | 0.193 | 0.045 | Alpha 1d adrenoreceptor agonist | 0.045 0.021 DB00316 | DB00316 | |
| 0.043 | 0.227 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.049 DB00316 | DB00316 | |
| 0.009 | 0.195 | 0.029 | Liver X receptor antagonist | 0.029 0.024 DBMET01974 | DBMET01974 | |
| 0.016 | 0.203 | 0.038 | Liver X receptor alpha agonist | 0.038 0.033 DBMET01974 | DBMET01974 | |
| 0.004 | 0.193 | 0.063 | Prostaglandin D2 antagonist | 0.063 0.005 DBMET01974 | DBMET01974 | |
| 0.032 | 0.221 | 0.086 | Secretase beta inhibitor | 0.086 0.03 DB00316 | DB00316 | |
| 0.032 | 0.224 | 0.077 | HIV-1 integrase inhibitor | 0.077 0.041 DBMET01974 | DBMET01974 | |
| 0.115 | 0.307 | 0.252 | RNA-directed DNA polymerase inhibitor | 0.252 0.048 DB00316 0.249 0.05 DBMET01974 | DB00316 | |
| 0.049 | 0.242 | 0.255 | Thrombolytic | 0.255 0.032 DBMET01974 | DBMET01974 | |
| 0.003 | 0.196 | 0.021 | Egl nine homolog 1 inhibitor | 0.021 0.005 DBMET01974 | DBMET01974 | |
| 0.075 | 0.269 | 0.349 | Hypolipemic | 0.349 0.036 DBMET01974 | DBMET01974 | |
| 0.003 | 0.199 | 0.023 | Prostaglandin E2 agonist | 0.023 0.017 DBMET01974 | DBMET01974 | |
| 0.015 | 0.214 | 0.051 | Plasminogen activator inhibitor antagonist | 0.051 0.031 DBMET01974 | DBMET01974 | |
| 0.068 | 0.269 | 0.159 | Cyclin-dependent kinase 8 inhibitor | 0.159 0.071 DB00316 | DB00316 | |
| 0.011 | 0.213 | 0.124 | NMDA 2 receptor antagonist | 0.124 0.023 DB00316 | DB00316 | |
| 0.047 | 0.249 | 0.189 | Bone formation stimulant | 0.189 0.039 DBMET01974 | DBMET01974 | |
| 0.042 | 0.244 | 0.061 | Calcium channel P-type blocker | 0.061 0.053 DBMET01974 | DBMET01974 | |
| 0.045 | 0.248 | 0.08 | Bromodomain-containing protein 2 inhibitor | 0.08 0.078 DB00316 | DB00316 | |
| 0.041 | 0.246 | 0.093 | Phosphodiesterase I inhibitor | 0.093 0.054 DBMET01974 | DBMET01974 | |
| 0.053 | 0.261 | 0.157 | Estrogen antagonist | 0.157 0.021 DB00316 | DB00316 | |
| 0.021 | 0.232 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.068 0.062 DB00316 0.095 0.036 DBMET01974 | DBMET01974 | |
| 0.007 | 0.218 | 0.068 | Integrin antagonist | 0.068 0.022 DBMET01974 | DBMET01974 | |
| 0.047 | 0.259 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.072 DB00316 | DB00316 | |
| 0.005 | 0.222 | 0.035 | HCV NS5B polymerase inhibitor | 0.035 0.018 DBMET01974 | DBMET01974 | |
| 0.02 | 0.242 | 0.057 | Thromboxane synthase inhibitor | 0.057 0.032 DBMET01974 | DBMET01974 | |
| 0.005 | 0.229 | 0.026 | Retinoid X beta receptor agonist | 0.026 0.01 DBMET01974 | DBMET01974 | |
| 0.069 | 0.294 | 0.144 | Death-associated protein kinase 3 inhibitor | 0.144 0.133 DB00316 | DB00316 | |
| 0.012 | 0.237 | 0.054 | Alpha tubulin antagonist | 0.054 0.036 DB00316 | DB00316 | |
| 0.009 | 0.235 | 0.031 | ATP citrate lysase inhibitor | 0.031 0.023 DBMET01974 | DBMET01974 | |
| 0.01 | 0.237 | 0.052 | Thromboxane A2 antagonist | 0.052 0.034 DBMET01974 | DBMET01974 | |
| 0.022 | 0.25 | 0.041 | Integrin alpha1beta1 antagonist | 0.041 0.02 DBMET01974 | DBMET01974 | |
| 0.04 | 0.273 | 0.135 | MAP kinase kinase inhibitor | 0.135 0.061 DB00316 | DB00316 | |
| 0.058 | 0.292 | 0.149 | Dual specificity phosphatase inhibitor | 0.149 0.095 DB00316 | DB00316 | |
| 0.014 | 0.25 | 0.067 | Prostaglandin-E synthase inhibitor | 0.067 0.053 DB00316 | DB00316 | |
| 0.021 | 0.257 | 0.052 | Glutamate (mGluR group III) antagonist | 0.052 0.019 DBMET01974 | DBMET01974 | |
| 0.032 | 0.268 | 0.062 | Phosphodiesterase 1C inhibitor | 0.062 0.044 DB00316 | DB00316 | |
| 0.01 | 0.248 | 0.046 | Glutamate (mGluR3) antagonist | 0.046 0.015 DBMET01974 | DBMET01974 | |
| 0.053 | 0.291 | 0.14 | Dual specificity phosphatase 3 inhibitor | 0.14 0.105 DB00316 | DB00316 | |
| 0.042 | 0.281 | 0.078 | MDM2 inhibitor | 0.078 0.023 DBMET01974 | DBMET01974 | |
| 0.012 | 0.252 | 0.056 | Thromboxane antagonist | 0.056 0.035 DBMET01974 | DBMET01974 | |
| 0.008 | 0.255 | 0.055 | Cyclin E inhibitor | 0.055 0.044 DB00316 | DB00316 | |
| 0.008 | 0.255 | 0.063 | Glutamate (mGluR1) antagonist | 0.063 0.036 DBMET01974 | DBMET01974 | |
| 0.007 | 0.256 | 0.037 | LFA antagonist | 0.037 0.009 DBMET01974 | DBMET01974 | |
| 0.025 | 0.274 | 0.054 | Glucosylceramidase inhibitor | 0.054 0.04 DB00316 | DB00316 | |
| 0.064 | 0.317 | 0.196 | Hepatoprotectant | 0.196 0.067 DBMET01974 | DBMET01974 | |
| 0.005 | 0.261 | 0.041 | Sphingosine 1-phosphate receptor 3 agonist | 0.041 0.021 DBMET01974 | DBMET01974 | |
| 0.02 | 0.279 | 0.069 | CYP2A6 inhibitor | 0.069 0.061 DBMET01974 | DBMET01974 | |
| 0.054 | 0.317 | 0.159 | Farnesoid X receptor antagonist | 0.159 0.043 DB00316 | DB00316 | |
| 0.003 | 0.273 | 0.034 | Prostaglandin H2 antagonist | 0.034 0.01 DBMET01974 | DBMET01974 | |
| 0.013 | 0.286 | 0.049 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.049 0.047 DB00316 | DB00316 | |
| 0.046 | 0.319 | 0.169 | Cell adhesion inhibitor | 0.169 0.036 DBMET01974 | DBMET01974 | |
| 0.134 | 0.409 | 0.244 | MAP kinase 1 inhibitor | 0.244 0.241 DB00316 | DB00316 | |
| 0.02 | 0.298 | 0.039 | CF transmembrane conductance regulator antagonist | 0.039 0.028 DB00316 | DB00316 | |
| 0.016 | 0.295 | 0.044 | Glutamate (mGluR8) antagonist | 0.044 0.012 DBMET01974 | DBMET01974 | |
| 0.008 | 0.291 | 0.02 | Tryptophan hydroxylase 1 inhibitor | 0.02 0.006 DBMET01974 | DBMET01974 | |
| 0.02 | 0.304 | 0.127 | Cyclin-dependent kinase 5 inhibitor | 0.127 0.054 DB00316 | DB00316 | |
| 0.002 | 0.287 | 0.015 | Egl nine homolog 3 inhibitor | 0.015 0.005 DBMET01974 | DBMET01974 | |
| 0.015 | 0.303 | 0.064 | Protein kinase C beta inhibitor | 0.064 0.059 DB00316 | DB00316 | |
| 0.032 | 0.321 | 0.111 | AMP-activated protein kinase stimulant | 0.111 0.058 DB00316 | DB00316 | |
| 0.031 | 0.321 | 0.094 | Aminoacyl-tRNA synthetase inhibitor | 0.094 0.052 DBMET01974 | DBMET01974 | |
| 0.04 | 0.33 | 0.15 | EphB2 antagonist | 0.15 0.13 DB00316 | DB00316 | |
| 0.031 | 0.325 | 0.081 | Cell adhesion molecule inhibitor | 0.081 0.052 DBMET01974 | DBMET01974 | |
| 0.053 | 0.35 | 0.095 | Folate antagonist | 0.095 0.074 DBMET01974 | DBMET01974 | |
| 0.029 | 0.33 | 0.119 | Protein kinase C gamma inhibitor | 0.119 0.053 DB00316 | DB00316 | |
| 0.006 | 0.312 | 0.031 | Retinoid X gamma receptor antagonist | 0.031 0.011 DBMET01974 | DBMET01974 | |
| 0.033 | 0.34 | 0.132 | Protein-tyrosine phosphatase inhibitor | 0.132 0.098 DB00316 0.121 0.112 DBMET01974 | DB00316 | |
| 0.016 | 0.323 | 0.1 | Sphingosine 1-phosphate receptor 5 agonist | 0.1 0.009 DBMET01974 | DBMET01974 | |
| 0.032 | 0.341 | 0.149 | Estrogen receptor beta antagonist | 0.149 0.016 DB00316 | DB00316 | |
| 0.036 | 0.347 | 0.147 | Mcl-1 antagonist | 0.147 0.092 DB00316 | DB00316 | |
| 0.011 | 0.332 | 0.051 | p53 inhibitor | 0.051 0.014 DBMET01974 | DBMET01974 | |
| 0.028 | 0.358 | 0.118 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.118 0.103 DB00316 | DB00316 | |
| 0.02 | 0.352 | 0.104 | Protein kinase C zeta inhibitor | 0.104 0.046 DB00316 | DB00316 | |
| 0.007 | 0.355 | 0.108 | Prostaglandin antagonist | 0.108 0.016 DBMET01974 | DBMET01974 | |
| 0.005 | 0.359 | 0.206 | Protocollagen prolyl hydroxylase inhibitor | 0.206 0.003 DBMET01974 | DBMET01974 | |
| 0.014 | 0.369 | 0.053 | Sphingosine kinase 2 inhibitor | 0.053 0.043 DB00316 | DB00316 | |
| 0.005 | 0.363 | 0.029 | Prostaglandin D2 agonist | 0.029 0.023 DBMET01974 | DBMET01974 | |
| 0.018 | 0.383 | 0.188 | M18 aspartyl aminopeptidase inhibitor | 0.188 0.037 DB00316 | DB00316 | |
| 0.029 | 0.394 | 0.189 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.189 0.085 DB00316 | DB00316 | |
| 0.033 | 0.4 | 0.103 | DNA polymerase I inhibitor | 0.103 0.083 DB00316 | DB00316 | |
| 0.026 | 0.404 | 0.202 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.202 0.091 DB00316 | DB00316 | |
| 0.025 | 0.414 | 0.193 | Dyrk kinase inhibitor | 0.193 0.102 DB00316 | DB00316 | |
| 0.048 | 0.458 | 0.203 | NOS3 expression enhancer | 0.203 0.039 DB00316 | DB00316 | |
| 0.06 | 0.488 | 0.273 | Antiobesity | 0.273 0.136 DBMET01974 | DBMET01974 | |
| 0.004 | 0.453 | 0.052 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.052 0.015 DB00316 | DB00316 | |
| 0.035 | 0.502 | 0.234 | Insulin secretagoues | 0.234 0.023 DBMET01974 | DBMET01974 | |
| 0.03 | 0.526 | 0.251 | Streptokinase A inhibitor | 0.251 0.102 DB00316 | DB00316 | |
| 0.005 | 0.502 | 0.058 | Prostaglandin EP2 antagonist | 0.058 0.043 DBMET01974 | DBMET01974 | |
| 0.028 | 0.528 | 0.079 | Interleukin 5 antagonist | 0.079 0.075 DB00316 | DB00316 | |
| 0.066 | 0.581 | 0.524 | Cyclophilin D inhibitor | 0.524 0.044 DBMET01974 | DBMET01974 | |
| 0.003 | 0.528 | 0.045 | Estrogen receptor beta agonist | 0.045 0.02 DB00316 | DB00316 | |
| 0.008 | 0.571 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.017 DB00316 | DB00316 | |
| 0.005 | 0.614 | 0.054 | NMDA 2B receptor antagonist | 0.054 0.037 DB00316 | DB00316 | |
| 0.002 | 0.639 | 0.034 | Estrogen receptor alpha agonist | 0.034 0.024 DB00316 | DB00316 | |
| 0.066 | 0.735 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.117 DB00316 | DB00316 | |
| 0.037 | 0.755 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.118 DB00316 | DB00316 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |